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ABSTRACT 
THE ROLE OF ENDOGENOUS BCl-XL IN REGULATION OF APOPTOTIC 
SIGNALING PATHWAYS 
Colins Ogwandi Eno 
September 27, 2012 
Bcl-2 proteins are major regulators of cellular responses to various apoptotic 
stimuli. Among them, overexpression of the anti-apoptotic BcI-2 protein Bcl-xL 
modulates organelle-specific apoptotic pathways. To understand the 
mechanisms by which endogenous BcI-XL regulates apoptosis, mouse embryonic 
fibroblasts (MEFs) deficient in Bcl-XL expression (Bcl-x-KO) was generated. 
Studies of Bcl-xL exclusively targeted to an organelle in Bcl-x-KO MEFs indicate 
that the mitochondria- and ER-Iocalized Bcl-xL play distinct roles in apoptosis 
resistance and Ca2+ homeostasis. Specifically, mitochondrial BcI-XL can regulate 
apoptosis independently of ER Bcl-XL, and when localized exclusively at the ER, 
BcI-XL impinges on Ca2+ homeostasis but does not affect apoptosis unless Bcl-xL 
is present in additional cellular compartments. Furthermore, I investigated how 
Bcl-2 proteins, especially Bcl-xL, might regulate oxidative stress-induced 
apoptosis. My studies reveal a signaling pathway, in which the oxidative stress 
inducer hydrogen peroxide (H202) activates Noxa, leading to a decrease in Mcl-1 
vii 
expression levels and subsequent increase in apoptosis in the absence of BcI-xL 
expression. Finally, I studied the exact roles of lysosomal membrane 
permeabilization in apoptosis cascade triggered by oxidative stress and how 
LMP is regulated by the complex Bcl-2 protein network. My studies elucidate a 
novel molecular mechanism that couples lysosomal membrane permeabilization 
with mitochondrial membrane permeabilization and ultimate cell death during 
oxidative stress-induced apoptosis. 
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1.1. Programmed cell death (Apoptosis) 
The word apoptosis is coined from Greek origin meaning "dropping off or falling 
off," and it is taken from the process by which leaves fall from trees or petals from 
flowers. Apoptosis is a biological process by which all multicellular organisms 
selectively eliminate damaged, infected, unwanted, or potentially neoplastic cells 
from the body [1-3]. It involves a programmed sequence of events ultimately 
resulting in the elimination of cells and/or cell debris. Apoptosis is one of the most 
common mechanisms by which the body eliminates damaged cells without local 
inflammation from leakage of cellular contents. Cell contents are eliminated from 
the body by phagocytic macrophages [4]. Apoptosis plays critical role in normal 
development, disease progression, and maintenance of tissue homeostasis, and 
serves as a defense strategy against the emergence of cancer [5]. Apoptosis is 
usually under stringent genetic control and can be activated by stimuli from 
multiple sources. 
Apoptosis occurs through a series of biochemical events which cause a large 
number of morphological changes in the cells including shrinking of the cells, 
blebbing of membrane, condensation and fragmentation of the nuclear material, 
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and formation of apoptotic bodies. In apoptotic cells, the membrane phospholipid 
phosphatidyl serine (PS), which is normally localized on the cytosolic side of cell 
membrane, becomes exposed on the extracellular side of the cell. The 
mitochondrial membrane breaks open with the release of apoptogenic proteins 
including cytochrome c and Diablo/Smac from the inter-membrane space (IMS) 
of the mitochondria to the cytosol ultimately leading to cell death [4, 6, 7]. 
Apoptosis is initiated in response to certain developmental signals or in the 
presence of various stimuli including deprivation of essential growth factors, 
binding of ligand receptors such as tumor necrosis factor receptors (TNFR) on 
cell surfaces, DNA damage, loss of cellular attachment, decrease in local 
concentration of tissue morphogens, or major changes in homeostatic state of 
the cell [3, 8]. 
Another form of cell death is known as necrosis. Cell death by necrosis differs 
from cell death by apoptosis, and it can be the result of injury, excessive stress or 
extreme exposure to intolerable physiological conditions including heat, toxins, 
hypothermia, mechanical trauma or hypoxia [9-11]. Morphological changes in 
cells undergoing necrosis include cell swelling, cell rupture, chromatin digestion, 
and disruption of organelle membranes such as the mitochondrial membrane 
(Figure 1.1) [11]. As a result, cell contents are released into surrounding tissues 
where they cause cellular and nuclear lysis, leading to an inflammatory response 
[11, 12]. Inflammatory response is not present in apoptotic cell death because 
cell debris and apoptotic bodies are removed by phagocytic macrophages. 
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Necrosis is almost always detrimental and can be fatal to the organism, whereas 
apoptosis is a natural cellular process that can either be detrimental or provide 
some beneficial effects to the organism. 
Dysregulation of apoptosis is implicated in the development of many disease 
states such as cancers and neurodegenerative diseases including Alzheimer's, 
Huntington's and Parkinson's diseases [13-15]. Excess or limited apoptosis can 
disrupt tissue homeostasis of multicellular organisms. If apoptosis occurs more 
than cell proliferation, neurodegenerative diseases will be exacerbated. 
Insufficient apoptosis on the other hand can accelerate cancer development [7, 
15]. Therefore, maintaining a balance between apoptosis and cell proliferation is 
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Figure 1.1. Morphological changes in cells during apoptosis and necrosis 
[11 ]. 
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1.2. Biological significance of apoptosis 
1.2.1. Proper development 
Since the 1930s, apoptosis has been recognized as an important process in 
development. The involvement of apoptosis in development has been well 
studied in three organisms: nematodes (Caenorhabditis elegans), fruit flies 
(Drosophila melanogaster) and mouse (Mus musculus). In C. elegans, during 
embryogenesis and soon after cell division, development of the hermaphrodite 
involves cell death of approximately 131 of the 1090 somatic cells through 
apoptosis [16]. In D. melanogaster, apoptosis is critical for the completion of 
development, and studies have shown that developmental disorders and/or 
death may occur once apoptosis is inhibited [5, 17]. 
During the early stages of development in the mammalian nervous system, about 
50% of neurons undergo apoptosis [18]. The formation of synapses between 
neurons in brain and spinal cord also requires the elimination of excess cells by 
apoptosis. During nerve cell development and attachment to their target cells and 
organs, more nerve cells are generated than their target cells. Excess nerve cells 
are eliminated by apoptosis to adjust the number of nerve cells to the size of 
target organ(s), thereby matching the number of developing nerve cells to the 
number of target cells and organs. During embryonic development, apoptosis 
helps to remodel tissues, sculpture the body, shape the organs, and carve out 
the fingers and toes. For instance, formation of proper fingers and toes in the 
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fetus requires removal of tissues between them by apoptosis. In this process, 
massive apoptosis occurs between the digits (fingers and toes), resulting in the 
separation of the digits (Figure 1.2A). Without sufficient apoptosis, the digits 
remain joined by soft tissues as seen in the duck hind limbs (Figure 1.28) [19]. 
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Figure 1.2. Apoptosis is important for proper development. (A) Cells 
between the digits undergo apoptosis to generate proper fingers and toes. 
(8) Insufficient apoptosis cause the cells in digits to remain joined by soft 
tissues as seen in the duck hind limbs [19] . 
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1.2.2. Maintenance of tissue homeostasis 
In an average human adult, billions of cells die every day due to apoptosis. Dead 
cells are constantly replaced with new cells originating from the body's stem cell 
populations [20]. Normal tissue homeostasis or constant internal environment is 
regulated by apoptosis. In a healthy organism, the rate of cell proliferation is 
approximately the same as the rate of apoptosis. This balance in apoptotic state 
is critical for the well-being of all multicellular organisms. If cells die more than 
they are being replaced, disease conditions such as neurodegeneration will be 
accelerated. On the other hand, insufficient apoptosis can result in cancer 
development [21]. Millions of Band T cells are generated daily in the immune 
system. The majority of these cells (> 95 %) die during maturation by apoptosis. 
Deletion of expanded effector T cells during immune responses, preservation of 
T cell memory and general homeostasis of immune cells are caused by 
apoptosis. 
1.2.3. Elimination of unwanted cells 
Abnormal cells, cells with unrepaired damaged DNA, and/or potentially 
neoplastic cells are eliminated from the body by apoptosis. Cells respond to DNA 
damage in one of three ways: (i) damaged DNA is either repaired by the cell's 
DNA repair machinery and cells resume their normal activity; (ii) damaged DNA 
can guide dividing cells into cell cycle arrest. Cell division stops until the 
damaged DNA is either repaired or destroyed. Cells resume normal cell cycle 
only when the damaged DNA is repaired; (iii) finally, if the damage to the DNA is 
8 
too severe to be repaired, cells are forced to undergo apoptosis. DNA damage in 
cells can disrupt proper embryonic development that induces severe teratogenic 
and mutagenic effects leading to development of many cancers [22, 23]. Cells 
therefore have developed protective defensive machinery to detect and repair 
damaged DNA or trigger apoptosis. In response to DNA damage, cells activate 
the genomic guardian protein p53 [24-26]. As a potent inducer of apoptosis, p53 
triggers apoptosis to eliminate the cells with irreparable DNA damage from the 
body. Most cancer cells often have defective p53 proteins which allow them to 
evade apoptosis and proliferate uncontrollably. 
Apoptosis also plays an important role in elimination of cells that pose threats to 
the organism. For example, self-reactive cells of the immune system and virally 
infected cytotoxic T cells are eliminated from the body by apoptosis [27]. 
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1.3. Pathways of apoptosis 
Apoptosis generally occurs through one of three signaling pathways, including 
the mitochondrial (intrinsic), the death receptor (extrinsic), and the mixed 
pathways. 
1.3.1. Intrinsic (mitochondrial) pathway of apoptosis 
Death stimuli generated from within the cell activate the intrinsic pathway of 
apoptosis. In the presence of death stimuli, signals are translocated to the 
mitochondria where they activate the pro-apoptotic 8c1-2 proteins, resulting in 
formation of permeation channels on the outer mitochondrial membrane (OMM) 
through which apoptogenic proteins including cytochrome c and Diablo/Smac 
leave the mitochondrial inter membrane space (IMS) and enter the cytosol. While 
in the cytosol, cytochrome c and Diablo/Smac activate a cascade of caspase 
reactions ultimately leading to apoptosis [28, 29]. Cytochrome c activates the 
apoptotic protease activating factor 1 (apaf-1), which in turn promotes the 
transition of the inactive forms of caspases (zymogen, pro-caspases) to their 
active counterparts (caspases), while Diablo/Smac directly interacts with 
inhibitors of apoptosis proteins (lAPs) and disrupts their ability to inactivate 













Caspase 3, 6, 7 
~ 
Apoptosis 
Figure 1.3. The intrinsic (mitochondrial) pathway of apoptosis. In the 
presence of apoptotic stimuli such as DNA damage, p53 is activated . 
Activated p53 then activates pro-apoptotic 8c1-2 protein members which 
interact on the OMM to form permeation channels which allow cytochrome 
C and Diablo/Smac to leave the mitochondria and enter the cytosol. In the 
cytosol , cytochrome c then initiates a caspase cascade ultimately leading 
to apoptosis, while Diablo/Smac interacts with lAPs and disrupts their 
ability to inhibit caspases thereby also leading to apoptosis. 
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1.3.2. Extrinsic (death receptor) pathway of apoptosis 
Unlike the intrinsic pathway of apoptosis where death signals are initiated from 
within the cell, death signals for extrinsic pathways of apoptosis are initiated from 
outside the cell. Activation of extrinsic pathways of apoptosis does not involve the 
mitochondria, interactions of the Bcl-2 proteins or release of cytochrome c from 
the mitochondrial IMS to the cytosol. Here, specific death ligands such as tumor 
necrosis factor (TNF), Fas Ligand (FasL) or TNF-related apoptosis-inducing 
ligand (TRAIL) bind to their respective specific transmembrane death receptors 
including Fas, tumor necrosis factor receptor 1 (TNFR1), p75, DR4 [32]. 
Binding of death ligands to their respective death receptor promotes the 
clustering and recruitment of the adaptor protein Fas-associated death domain 
(FADD) and the inactive forms of the initiator caspases 8 and 10 (pro-caspases 8 
or 10), thereby forming the death-inducing signaling complex (DISC). Therefore, 
the DISC is made up of the FADD, caspase 8 and caspase 10. The DISC brings 
the pro-caspase molecules in close proximity, ensuring access for their 
autocatalysis and release into the cytosol [33-37]. Caspase 8 or 10 then 
activates the effector caspases 3/6/7 in a caspase cascade reaction leading to 
apoptosis (Figure 1.4). 
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Figure 1.4. The extrinsic (death receptor) pathway of apoptosis. Extrinsic 
apoptotic signaling pathway is generated from outside the cell. Initiation of 
apoptosis results in binding of death ligands to specific transmembrane 
death receptors, which causes clustering and recruitment of the adaptor 
molecule FADD, procaspase 8, 10 to form the DISC, subsequently 
activating-caspase 8, 10. Caspase 8, 10 then activates caspase 3/6/7 
ultimately leading to apoptosis. 
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1.3.3. The mixed pathway of apoptosis 
While activation of apoptosis in most cells can be initiated either from within the 
cell (intrinsic) or outside the cell (extrinsic), there are certain instances where 
induction of apoptotic signaling pathways from external sources can also lead to 
activation of both intrinsic and extrinsic apoptotic pathways (mixed pathway). In 
this paradigm, death stimuli generated from outside the cell cause activation of 
pro caspase 8, pro caspase10, and formation of the DISC in a similar fashion as 
observed with the extrinsic pathways. The formation of the DISC will ultimately 
lead to autocatalysis and activation of caspase 8 and 10 [33-37]. 
Activated caspase 8 can enter one of two routes: (i) it can activate the effector 
caspases 3, 6 and 7, leading to apoptosis as in the extrinsic pathway or (ii) it can 
enter the intrinsic pathway of apoptosis by interacting with the BcI-2 family of 
proteins. In this case, caspase 8 cleaves the inactive pro-apoptotic BH3-only 
protein Bid into its truncated (activated) form (tBid). The tBid then activates the 
BcI-2 proteins Bax and Bak at the OMM. Bak and Bax undergo conformational 
changes and oligomerize resulting in formation of permeation pores on the OMM. 
Cytochrome c and Diablo/Smac then are released from the mitochondrial IMS 
into the cytosol where they exert their pro-apoptotic effects in the same fashion 









Caspases S, 10 --+ ! 
--1 Bcl-2/Bcl-xL tBid 
1-
BaxiBak 
• ~. .,m,,,m,",o 
" .... . / 
Cytochrome c lAPs 
+'/ Caspase 9 
~ 




Figure 1.5. The mixed pathway of apoptosis. Stimuli from extracellular 
sources lead to DISC formation and activation of caspases 8 and 10. 
Activated caspase 8 and 10 can either cleave effector caspases to cause 
cell death (as with the extrinsic pathway) or can enter the intrinsic pathway 
by interacting with the Bcl-2 family of proteins. Caspase 8 converts full-
length Bid into tBid which then interacts with Bax!Bak inducing their 
oligomerization and formation of permeation pores on the OMM, allowing 
apoptogenic proteins such as cytochrome c and Diablo! Smac from the 
mitochondria into the cytosol where they exert their effects. 
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1.4. Regulation of apoptosis 
Apoptosis is primarily regulated by the caspases and the Bcl-2 family of proteins. 
1.4.1. Caspases 
Caspases are a group of cysteine proteases which cleave proteins at sites 
proximal to aspartic acid residues [38]. Caspase activation usually is considered 
the molecular hallmark of apoptosis [39]. Caspases exist in their inactive forms 
(pro-caspase), and are activated during apoptosis by pro-apoptotic proteins [40]. 
To date about 12 caspases have been identified, but not all caspases are 
involved in regulation of apoptosis. For instance, caspase 1 is critical for the 
regulation of the biological processes irrelevant to cell death including maturation 
of red blood cells and skeletal muscle myoblasts, while caspase 14 is essential in 
skin cell development [41]. 
Two classes of caspases involved in apoptosis are the initiator (apical) and the 
effector (executioner) caspases. Initiator caspases, including caspases 2, 8, 9 
and 10, are activated in response to upstream apoptotic stimuli. Initiator 
caspases cleave and process the effector caspases 3, 6 and 7. Once activated, 
effector caspases are responsible for triggering cell death by degrading key 
structural proteins within cells. 
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1.4.2. The Bcl-2 proteins 
The BcI-2 family of proteins is one of the major regulators of the intrinsic pathway 
of apoptosis. They derived their name from B-cell/ymphoma//eukemia 2, as the 
second member of a range of proteins initially discovered during chromosomal 
translocations involving chromosomes 14 and 18 in human follicular lymphomas 
[42]. BcI-2 is the founding members of the Bcl-2 family of proteins and is encoded 
by Bcl-2 gene [43]. To date, approximately 20 different members of the Bcl-2 
protein family have been identified. Members of the Bcl-2 family of proteins all 
share one to four homologous BcI-2 homology (BH) domains important for homo-
and hetero-dimeric interactions among different family members. Bcl-2 proteins 
can be pro-apoptotic or anti-apoptotic [3, 44, 45] based on the number of BH 
domains and their ability to regulate apoptosis [46]. 
1.4.2.1. The pro-apoptotic Bcl-2 proteins 
The pro-apoptotic BcI-2 proteins are critical for the initiation and or activation of 
the intrinsic pathway of apoptosis. They are divided into two structurally and 
functionally distinct categories: multidomain and BH3-only Bcl-2 proteins [47]. 
1.4.2.1.1. The multidomain pro-apoptotic Bcl-2 proteins 
The multidomain pro-apoptotic BcI-2 proteins Bax, Bak and Bok share three BH 
domains (BH1-BH3). They are responsible for forming permeation channels on 
the OMM, which in turn disrupt mitochondrial membrane integrity during 
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apoptosis thus allowing the release of apoptogenic proteins from the 
mitochondria to the cytosol. While Bax and Bak are ubiquitously present in all 
tissues, Bok is expressed only in reproductive cells [48]. In healthy cells, Bax and 
Bak are localized in different subcellular compartments. Bak is constitutively 
integrated in the OMM, while Bax is localized in the cytosol. The carboxyl-
terminal membrane-anchoring region of Bax is normally sequestered into its 
hydrophobic pocket keeping Bax constitutively inactive in the cytosol [49). But in 
the presence of death stimuli, Bax undergoes conformational changes at both the 
amino- and carboxyl- termini, leading to its translocation to the OMM and 
eventual formation of large oligomeric complexes [50, 51]. Since Bak resides 
solely in the mitochondria, in the presence of apoptotic stimuli Bak changes 
conformation and forms oligomeric complexes as well [52). Oligomeric Bax and 
Bak form permeation channels on OMM to facilitate the release of cytochrome c 
and Smac/Diablo from mitochondrial IMS to the cytosol where they carry out their 
pro-apoptotic functions. 
Bax can also be activated in ER during apoptosis [53]. Studies have shown that 
most mice deficient in both Bax and Bak (double knockout, DKO) die during 
embryonic stages, but the few that survive to adulthood have an accumulation of 
excessive cells in various tissues [54]. Cells from Bax and Bak DKO mice are 
highly resistant to apoptosis induced by all stimuli triggering the mitochondrial 
signaling apoptotic pathway [54]. Activation of Bax and Bak proteins are 
therefore critical for the initiation of apoptosis in mammalian cells. 
19 
1.4.2.1.2. The pro-apoptotic BH3-only Bcl-2 proteins 
The pro-apoptotic BH3-only Bcl-2 proteins, including Noxa, tBid, Puma, Bim, 
Bmf, Bik, Nix, Bnip3, Bad, and Hrk, all have only a single BH3 domain in 
common [6]. The BH3 domain is an interactive domain that is necessary and 
sufficient for the killing action of BH3-only Bcl-2 proteins. They are activated by 
many diverse apoptotic stimuli, including deprivation of essential growth factor, 
cell-cell or cell-matrix interactions, ER stress, exposure to physical or chemical 
DNA damaging agents, viruses, bacteria, or TNF-like cytokines via transcriptional 
upregulation, changes in subcellular localization, altered protein stability or post-
translational modifications. Not all BH3-only BcI-2 proteins are activated by a 
single apoptotic stimulus. They are always under stringent control at the 
transcriptional and post-translational levels [6]. 
1.4.2.1.2.1. Transcriptional and post-translational regulation of BH3-only 
Bcl-2 proteins 
As mentioned earlier, the BH3-only BcI-2 proteins are under strict transcriptional 
and/or post-translational control. Different BH3-only Bcl-2 proteins are activated 
by various stimuli through different mechanisms, depending on the cell type and 
the type of stimuli present. The BH3-only Bcl-2 proteins Puma, Noxa, Bim and 
Hrk are subject to stringent transcriptional control, whereas the rest of the other 
BH3-only Bcl-2 proteins are mostly activated by post-translational modification. 
Both Noxa and Puma are activated by the tumor suppressor protein p53 usually 
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in the presence of apoptotic stimuli that generate stress to the cell such as DNA 
damage [55, 56]. DNA damage causes p53 activation subsequently increasing 
Noxa and Puma mRNA and protein expression in thymocytes and fibroblasts [55, 
56]. Transcriptional control of Bim is much more complex and different from that 
of Puma and Noxa. Withdrawal of essential growth factors cause increased 
expression of Bim in both neuronal [57] and hematopoietic cells [58]. Bim 
expression is also induced transcriptionally by ER stress through the transcription 
factor CHOP [59]. In apoptotic cells Bim is stabilized by JNK, and in healthy cells 
it is destabilized by Erk1/2 [60, 61]. Hrk is induced during embryogenesis in 
neuronal tissues containing relatively large number of apoptotic cells including 
the trigeminal and dorsal root ganglia, and the anterior horn of the spinal cord 
[62]. In murine myeloid and lymphoid progenitor cells, withdrawal of essential 
growth factor induces Hrk expression sufficient to trigger apoptosis [63]. Hrk is 
also activated transcriptionally by stress activated/c-jun N-terminal kinase 
(SAPKlJNK) [64, 65]. 
Other BH3-only BcI-2 proteins, including Bad, Bik, Bid, Bim and Bmf, are 
regulated by post-translational modification, which makes them active and 
available to interact with other proteins. Bad is activated by dephosphorylation 
and deactivated by phosphorylation. Bad is deactivated by phosphorylation at 
several serine residues (S-112, S-136 and S-155) by kinases including AKT, 
protein kinase A (PKA), and Raf-1[66-68]. In cells undergoing apoptosis, Bad is 
dephosphorylated by the phosphatases protein phosphatase 2A (PP2A) or 
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calcineurin [69]. Like Bad, Bik is also modified post-translationally by 
phosphorylation. However, phosphorylation of Bik by casein kinase II or related 
enzymes activates Bik protein [70]. In contrast to Bad and Bik, Bid is activated by 
a different post-translational modification mechanism. In healthy cells, inactive 
full-length Bid is localized in the cytosol. In the presence of apoptotic insults, Bid 
is processed by caspase 8 into its truncated fragment, tBid [71]. The tBid is then 
translocated to the mitochondria where it interacts with pro-apoptotic multidomain 
Bcl-2 proteins including Bax and Bak to exert its pro-apoptotic activities. 
In addition to transcriptional activation, Bim is also activated post-translationally. 
Bim and Bmf are two BH3-only BcI-2 proteins regulated by sequestration of 
cytoskeleton structure inside cells [72]. In healthy cells, Bim is sequestered to the 
microtubule dynein motor complex through its interaction with Dynein Light Chain 
1 (DLC1/LC8) [72]. Bmf is sequestered to the actin cytoskeleton-based myosin V 
motor complex through its interaction with dynein light chain. In response to 
stress stimuli such as detachment of cells from the substratum (anoikis) or drugs 
that depolymerize actin, Bmf is released to trigger apoptotic signaling. 
The different pro-apoptotic BH3-only BcI-2 proteins are activated based on the 
type of stress to the cell. The BH3-only BcI-2 proteins interact with either anti-
apoptotic members (Bcl-XL, BcI-2, and Mcl-1) or pro-apoptotic multidomain 
members (Bax and Bak) at the mitochondria level to exert their pro-apoptotic 
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effects. Recent studies suggest that the interaction between BH3-only Bcl-2 
proteins with anti-apoptotic or pro-apoptotic multidomain BcI-2 proteins also take 
place on the ER membrane thereby making the ER an important organelle for 
initiation and activation of apoptosis [73]. 
1.4.2.2. The anti-apoptotic Bcl-2 proteins 
To date, five anti-apoptotic Bcl-2 proteins have been identified in mammals, 
including Bcl-XL, Bcl-2, McI-1, Bcl-w, and A 1. The anti-apoptotic BcI-2 proteins 
share up to four conserved BH domains (BH 1-BH4) and the membrane-targeting 
hydrophobic carboxy terminal regions. The anti-apoptotic BcI-2 proteins delay or 
prevent apoptosis [15]. They are mostly localized on membrane surfaces 
including the OMM, the nuclear membrane, and the ER membrane [74]. The anti-
apoptotic Bcl-2 proteins maintain the OMM integrity and protect cells against a 
wide range of apoptotic stimuli, therefore they are essential for cell survival [46, 
74, 75]. The activities of the anti-apoptotic Bcl-2 proteins have been well 
examined both by overexpression and gene targeting knock-out studies. 
Overexpression of all anti-apoptotic Bcl-2 proteins has shown protection of cells 
from apoptosis initiated by various apoptotic stimuli [3]. A more defined function 
of each of the five anti-apoptotic Bcl-2 proteins has been established using the 
gene targeting studies in diverse cell types and tissues [3, 76, 77]. 
23 
The founding member Bcl-2 is required for the survival of mature lymphocytes, 
melanocyte stem cells and cells of developing kidneys [78, 79]. BcI-xL and Mcl-1 
are important for embryonic development, and embryos deficient in either BcI-xL 
or McI-1 do not survive. Embryos lacking Bcl-XL expression die in utero, with 
extensive apoptosis throughout their developing nervous and hematopoietic 
systems [80]. In addition, BcI-xL is also required for the survival of mature 
erythrocytes [81, 82]. Mcl-1 deficiency caused failed implantation. By studying 
conditional knockout mice, McI-1 is shown to be essential for survival of the 
hematopoietic progenitors, mature B- and T - lymphocytes [83]. Bcl-w is required 
for sertoli cell survival in the testis [84] and A 1 is critical for neutrophil survival 
[85]. The exact molecular and biochemical mechanisms by which anti-apoptotic 
BcI-2 proteins keep cells alive is controversial and has not yet been universally 
accepted. Depending on the nature of stress to the cells, the anti-apoptotic BcI-2 
proteins specifically suppress the activities of the pro-apoptotic Bcl-2 proteins to 
maintain cell viability. 
1.4.2.2.1. The bc/-x gene 
One of the mammalian genes identified as a suppressor of apoptosis is the bc/-x 
gene [86]. Boise et al (1993) first discovered the bc/-x gene in chicken, and 
identified two distinct Bcl-x cDNAs in human: BCl-XL and BCl-xs, generated from 
alternative splicing of the Bcl-x [12]. BCl-XL and BCl-xs have similar structure 
except that an internal deletion of 63 amino acids of Bcl-XL due to alternative 
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splicing generates Bcl-xs. Whereas Bcl-XL contains all the four BH domains 
[BH( 1-4)], Bcl-xs has only two of the four BH domains [BH(3-4)]. Bcl-XL has 
remarkable amino acid and structural homology to the founding member of the 
BeI-2 family proteins, Bcl-2. Bcl-XL was shown to prevent apoptosis in interleukin-
3 (IL-3)-dependent cells following deprivation of essential growth factor, but this 
was not the case with Bcl-xs. Instead, BeI-Xs promoted apoptosis by inhibiting the 
death suppressor activities of Bcl-2. Therefore, Bel-XL and Bcl-xs display opposite 
activities in apoptotic regulation [12]. Later studies have shown that Bcl-XL inhibits 
apoptosis by forming hetero-dimeric complexes with pro-apoptotic BeI-2 proteins 
making them inactive [87]. The role of Bcl-xs in apoptosis is poorly understood, 
but is mostly considered pro-apoptotic [81]. Some studies suggest that BeI-Xs 
antagonizes the anti-apoptotic functions of Bcl-XL [88, 89], but it is unclear 
whether BeI-xs functions simply as an inhibitor of anti-apoptotic BeI-2 proteins or 
if it can directly induce apoptosis. Bcl-XL and BeI-xs are expressed in variety of 
tissues and their expression is differentially regulated [12]. In cells, Bel-XL is 
localized on the mitochondria, the ER and the perinuelear envelope. Bel-XL is the 
dominant form of the Bcl-x mRNA expressed in murine tissues during 
embryogenesis and postnatal development. 
Like other anti-apoptotic BeI-2 proteins, Bcl-XL is overexpressed in many cancer 
cells including breast cancer cells, neuroblastomas, myelomas, lymphomas and 
hepatomas [74, 75]. Extremely high levels of Bel-XL in cancer cells make them 
resistant to chemotherapeutic agents leading to limited apoptosis and poor 
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clinical outcome [74]. Therefore, new drugs designed to reduce BcI-XL expression 
levels in these cancer cells will complement current cancer therapies. 
1.4.2.3. Regulation of OMM permeabilization by the Bcl-2 proteins 
How the BcI-2 proteins interact at mitochondrial and ER membrane levels to 
regulate apoptosis is still controversial and unclear. Genetic and biochemical 
studies showed that Bax and Bak are required for apoptosis and outer 
mitochondrial membrane permeabilization (OMMP) [90]. The pro-apoptotic BH3-
only Bcl-2 proteins are categorized into two groups based on their ability to 
interact with Bax and Bak, or the anti-apoptotic BcI-2 proteins. Two models for 
Bax and Bak activation have been proposed including the direct activation and 
the displacement models [74]. 
In the direct activation model, the BH3-only BcI-2 proteins are again classified 
into two groups known as the direct activators, including Bim, tBid, and Puma, 
and the sensitizers (de-repressor), including the rest of the BH3-only Bcl-2 
proteins [91]. For the direct activator BH3-only Bcl-2 proteins, direct activators 
directly interact with Bax and Bak. Here, in healthy cells, the direct activators are 
constitutively active and are kept inactive by forming hetero-dimeric complexes 
with anti-apoptotic Bcl-2 proteins. But in dying cells, the direct activators are 
dissociated from their anti-apoptotic binding partners by various mechanisms, 
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and interact directly with Bax and Bak leading to their activation. The interaction 
between Bax and Bak and the direct activators BH3-only Bcl-2 proteins is the 
main event necessary for engagement of OMMP. In contrast, activation of Bax 
and Bak by the sensitizers BH3-only Bcl-2 proteins is much different. Unable to 
directly interact with Bak and Bax, the sensitizer BH3-only BcI-2 proteins cannot 
induce Bax and Bak activation directly [74]. Instead, the sensitizers bind to the 
anti-apoptotic Bcl-2 proteins with high affinity freeing them from their complexes 
with the direct activator BH3-only Bcl-2 proteins. The released direct activators in 
turn initiate Bax- and Bak-mediated OMM permeabilization and subsequent 
apoptosis cascade [92]. 
Another proposed model for activation of Bax and Bak is the displacement 
model. In this model, Bax and Bak with constitutive activity are kept inactive by 
forming complexes with the anti-apoptotic BcI-2 proteins. But in cells undergoing 
apoptosis, BH3-only BcI-2 proteins bind to these anti-apoptotic BcI-2 proteins 
with higher affinity and displace them from their complexes with Bax and Bak. 
Freed Bax and Bak are now activated and are able to induce OMM 
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Figure 1.6. Activation of outer mitochondrial membrane permeabilization by 
Bcl-2 protein family. (A) Direct activation model. Here, the BH3-only 
BcI-2 proteins are classified into two groups known as the direct 
activators, including Bim, and the sensitizers including Noxa. The direct 
activator BH3-only BcI-2 proteins Bim, tBid and Puma interact directly with 
Bax and Bak leading to their activation and subsequent apoptosis. The 
sensitizer BH3-only Bcl-2 proteins Noxa and Bad do not interact with Bax 
and Bak directly. Instead, the sensitizers bind to the anti-apoptotic Bcl-2 
proteins with high affinity freeing them from their complexes with the direct 
activator BH3-only BcI-2 proteins. The released direct activators in turn 
initiate Bax- and Bak-mediated OMM permeabilization and subsequent 
apoptosis. (B) Displacement model. In this model, Bax and Bak with 
constitutive activity are kept inactive by forming complexes with the anti-
apoptotic Bcl-2 proteins. But in cells undergoing apoptosis, BH3-only Bcl-2 
proteins bind to these anti-apoptotic Bcl-2 proteins with higher affinity and 
displace them from their complexes with Bax and Bak. Freed Bax and Bak 
are now activated and are able to induce OMMP and subsequent 
apoptosis. 
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1.5. Hypothesis and significant of the project 
1.5.1. Hypothesis and specific aims 
In this thesis, we specifically addressed the molecular, and biochemical 
mechanisms through which endogenous Bcl-XL regulate apoptotic signaling 
pathways. As mentioned earlier, the BcI-XL protein is generated from alternative 
splicing of Bcl-x. Previous studies have shown that mouse embryos deficient die 
Bcl-x around day 13 of embryogenesis [80]. BcI-x is therefore indispensable for 
embryonic development. Regulation of both the expression and splicing of Bcl-x 
during development is important in the determination of susceptibility of cells to 
apoptosis [80]. 
In this thesis, we first developed mouse embryonic fibroblasts (MEFs) either 
deficient in BcI-x (knock out, BcI-x-KO) or expressing Bcl-x (wild type, BcI-x-WT). 
MEFs were then used to study the molecular mechanisms by which endogenous 
Bcl-XL regulates apoptotic signaling pathways. Our overall hypothesis is that 
intracellular localization of endogenous Bcl-XL is critical for its anti-
apoptotic activities and that endogenous Bcl-XL coordinates with other 
members of the Bcl-2 protein family to regulate apoptosis. Previous studies 
have shown that overexpression of BcI-XL in cells renders them resistant to 
apoptosis insults. The exact mechanism of how endogenous BcI-XL prevents 
apoptosis is still unclear and controversial. One possible explanation is that 
previous research focused on cells overexpressing BcI-XL many fold higher than 
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its physiological functional level. As Bcl-XL likely functions by modulating OMM 
integrity, enforced overexpression of Bcl-XL could relocate Bcl-xL protein to non-
physiological locations inside cells, leading to unexpected biological 
consequences. Therefore, studying the activities of Bcl-xL at the endogenous 
levels will fill critical gaps in our understanding of the molecular and biochemical 
mechanisms of BcI-xL, and might provide potential targets for cancer therapy. We 
proposed the following specific aims to examine this hypothesis: 
Specific aim 1: Investigate how mitochondria- and ER-Iocalized Bcl-XL 
regulate apoptosis and Ca2+ homeostasis. Previous studies have shown that 
anti-apoptotic Bcl-2 proteins regulate apoptosis initiated from different 
intracellular organelles. As endogenous Bcl-xL is localized in the mitochondria, 
the ER, and the cytosol, we investigated the effects of Bcl-XL targeted to these 
organelles on apoptosis regulation and Ca2+ homeostasis. The carboxyl-terminal 
transmembrane domain of Bcl-xL which specifically targets BcI-xL to the cytosol 
was deleted, and replaced with either the mitochondrial targeting sequence of 
listerial (ActA) or the ER targeting sequence of cytochrome b5 (Cb5) which 
targets BcI-XL to the mitochondria or the ER respectively. These mutant Bcl-XL 
proteins were re-expressed in BcI-x-KO MEFs at levels comparable to that of 
endogenous Bcl-xL. BcI-x-KO MEFs re-expressing different BcI-xL mutants were 
used to investigate the effects of BcI-XL proteins localized on different organelles 
in the regulation of apoptotic stimuli and Ca2+ homeostasis. 
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Specific Aim 2: Study how endogenous Bcl-XL regulates oxidative stress-
induced apoptosis. Oxidative stress inducers, including hydrogen peroxide 
(H202), cause necrosis and apoptosis. Mild to moderate oxidative stress triggers 
apoptosis while severe oxidative stress causes necrosis [93]. The exact 
mechanism through which oxidative stress inducers promote apoptosis is unclear 
but recent evidence suggests the involvement of the Bcl-2 proteins. Here, we 
systematically explored the role of BcI-2 proteins, particularly Bcl-xL, in the 
regulation of H202-induced apoptosis. 
Specific Aim 3: Examine the important role of LMP during oxidative stress-
induced apoptosis. Lysosomal membrane permeabilization (LMP) is important 
in H202-induced apoptosis. However, the exact role of LMP in H202-induced 
apoptosis or how it is regulated by the complex BcI-2 network is unclear. Here, 
we investigated the role of LMP in regulating oxidative stress-induced apoptosis 
by examining the temporal relation between LMP and OMM permeabilization. 
1.5.2. Significance of the Project 
Results from this project elucidate the detailed mechanisms through which 
endogenous BcI-XL regulates apoptosis. The data provide information for new 
chemotherapeutic drug targets. Since BcI-xL is highly expressed in many cancer 
cells to enable them evade apoptosis, drugs designed to inhibit BcI-XL activities 




DISTINCT ROLES OF MITOCHONDRIAl- AND ER-lOCALIZED BCl-XL 
IN APOPTOSIS REGULATION AND Ca2+ HOMEOSTASIS 
2.1. Introduction 
The Bcl-2 family of proteins is major regulator of cellular response to apoptotic 
signaling [45]. Since the founding family member BcI-2 was shown to protect 
cells from apoptotic insults [94], more than 20 BcI-2-related proteins have been 
identified possessing either anti- or pro-apoptotic functions [45]. Among anti-
apoptotic members, BcI-XL retains the prototypical structural organization of four 
BH domains [BH( 1-4)] and a membrane-targeting hydrophobic carboxyl terminal 
region [12, 95]. One important characteristic of BcI-2 proteins is that they display 
differential interactions with each other and with other regulatory proteins in the 
apoptotic cascade, thus profoundly influencing apoptosis [75, 96, 97]. 
Recent genetic and biochemical studies have revealed a conserved cascade that 
leads to the disruption of OMM integrity and the release of apoptosis-inducing 
factors into the cytosol, subsequently resulting in destruction of cells [12, 98, 99]. 
While anti-apoptotic BcI-2 proteins are generally believed to promote cell survival 
by preventing OMM disintegration, pro-apoptotic Bcl-2 family members facilitate 
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OMM permeabilization during apoptosis [74, 100]. Although most studies have 
focused on how Bcl-2 proteins modulate OMM integrity during apoptosis, there is 
a large body of evidence indicating that BcI-2 proteins are also localized and 
function on the ER membrane [101, 102]. It has been proposed that ER-resident 
pro-apoptotic BcI-2 proteins sense insults to the ER, resulting in death-signals 
being communicated from the ER to the mitochondria, or apoptosis being directly 
initiated at the ER level [103-105]. 
The involvement of ER in anti-apoptotic signaling has been linked to its role as 
intracellular Ca2+ store [104]. Protection of apoptosis induced by overexpression 
of anti-apoptotic BcI-2 proteins including BcI-2, BcI-XL or McI-1 can be attributed 
partially to their ability to modulate ER Ca2+ signals through interactions with the 
inositol 1,4,5-trisphosphate receptor (InsP3R) Ca2+ release channel [106-110]. 
While these studies have been highly informative, they rely largely on 
overexpression systems to study anti-apoptotic BcI-2 proteins, which might not 
reveal the activities of endogenous proteins. More importantly, there have been 
no studies designed to examine the specific functions of BcI-XL at distinct 
organelles in non-overexpression systems. 
To address this, we generated Bcl-x-deficient (Bcl-x-KO) MEFs to study the 
effect of organelle-specific BcI-XL reexpression on apoptosis and ER Ca2+ 
homeostasis. Bcl-x-KO MEFs displayed increased sensitivity to apoptosis and 
disrupted ER Ca2+ homeostasis. Expressing mitochondrially targeted Bcl-XL in 
34 
these MEFs increased apoptotic protection to the levels comparable to wild-type 
MEFs In contrast, expression of ER-Iocalized Bcl-xL completely restored ER Ca2+ 
homeostasis but had no effect on apoptotic protection. When expressed in the 
wild-type Bcl-xL background, however, ER-targeted Bcl-XL did increase apoptotic 
protection. These data show that mitochondrial localization alone is sufficient to 
provide protection, but also that it is an absolute requirement for ER-Iocalized 
Bcl-xL to be anti-apoptotic. 
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2.2. Materials and Methods 
2.2.1. Reagents 
Etoposide, doxorubicin, H202 and actinomycin 0 were all purchased from Sigma 
(St. Louis, MO), while staurosporine was purchased from Enzo (Farmingdale, 
NY). All reagents were dissolved in dimethyl sulfoxide (OMSO). Lipofectamine 
2000 was purchased from Invitrogen (Carlsbad, CA). Unless otherwise stated, all 
other reagents were purchased from Sigma. Antibodies used for western blot and 
immunofluorescence analyses were anti-BcI-xS/L S-18 pAb (Santa Cruz, CA, Cat. 
# sc-634), anti-~-actin mAb (Sigma), anti-Bak pAb (Upstate; Lake Placid, NY, 
Cat. # 06-536 NT), anti-Bax N20 pAb (Santa Cruz, Cat. # sc-493), anti-McI-1 pAb 
(Epitomics; Burlingame, CA, Cat. # 1239-1), anti-Bcl-2 mAb (Santa Cruz, sc-
7382), anti-Bcl-w mAb (Cell Signaling Technology, Cat. # 31H4), anti-calreticulin 
pAb (Stressgen, Cat. # SPA-600), anti-Tom20 pAb (a gift from Dr. Brian 
Wattenberg), peroxidase-conjugated goat anti-rabbit IgG (Thermo; Waltham, MA, 
Cat. # 31460), peroxidase-conjugated goat anti-mouse IgG (Thermo, Waltham, 
MA, Cat. # 31430), and Alexafluor 594 goat anti-rabbit IgG (Molecular Probes; 
Eugene, OR). 
2.2.2. Bel-XL expression vector construction 
The human BcI-XL cONA was cloned into the mammalian expression vector 
pEF6/myc-His A (Invitrogen) to generate the plasmid pEF6-BcI-xL. A stop codon 
was introduced after amino acid 210 by polymerase chain reaction (PCR) to 
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generate pEF6-BcI-xL -~C. The carboxyl-terminal transmembrane region of Bcl-XL 
was replaced by the cytochrome b5 (cb5) membrane targeting sequence which 
directs Bcl-XL specifically to the ER membrane, or the membrane targeting 
sequence of the listeria protein ActA, which specifically targets BcI-XL to the 
mitochondria generating pEF6-BcI-xL-cb5 and pEF6-Bcl-xL-ActA respectively. 
The constructs used for intracellular localization experiments were generated by 
subcloning appropriate cDNA fragments from pEF6 into pEGFP-C1 (Clontech; 
Madison, WI). The respective Bcl-XL mutant plasm ids were expressed into the 
Bcl-x-KO MEFs and single clones selected using the limited dilution method. 
Clones whose BcI-XL expression levels were comparable to wild type levels 
determined by western blot analysis were selected for further studies. 
2.2.3. Generation of cell lines 
Embryos from an eleven day pregnant Bc/-x heterozygous mouse were isolated. 
Primary embryonic cells were dissociated and plated on gelatin-coated dishes. 
Seven days later, adherent embryonic cells were immortalized by transfecting 
with the pCDNA3 plasmid expressing SV40 large T antigen. The limiting dilution 
method was used to isolate single clones from each of the 10 original embryos. 
After stable cell lines were established, the expression of Bcl-XL was examined by 
western blot (Figure 2.1A). While expression of BcI-xL in the established MEFs 
was readily detected by western blot analysis, expression of BcI-xs was 
undetectable, indicating that BcI-xL is the predominant splicing product in MEFs 
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(Figure 2.1 B). Among ten MEFs developed (from ten different embryos), cell 
lines 1, 3, 5 and 6 had higher Bcl-XL expression and were considered to express 
Bcl-XL from both alleles (bcl-x+I+, designated wild-type, BcI-x-WT). In contrast, 
BcI-XL was not detected in cell lines 2, 4 and 9, designated as Bcl-x-KO MEFs 
(bcl-x-I-, knock-out, BcI-x-KO). In cell lines 7, 8, and 10, lower BcI-xL expression 
were detected, which could be attributed to heterozygous deletion of the bcl-x 
gene (bcl-x+I-). 
To re-express Bcl-xL in BcI-x-KO MEFs, pEF6 plasmids encoding wild-type or 
mutant Bcl-xL cDNAs were transfected into wild-type or BcI-x-KO MEFs using 
lipofectamine 2000 reagent (Invitrogen). MEFs stably expressing BcI-XL proteins 
were obtained by growing transfected cells in the medium containing 1.5 Ilg/ml 
blasticidin antibiotics (Invitrogen) and subcloned by a limited dilution approach. 
Western blot analysis then was used to determine the expression level of 
different Bcl-XL proteins in Bcl-x-KO MEFs. All MEFs were cultured in DMEM 
(Mediatech; Manassas, VA) supplemented with 10% FBS (Gemini; West 
Sacramento, CA), 100 U/ml penicillin (Mediatech), and 100 IJg/ml streptomycin 
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Figure 2.1. Generation of wild-type and 8cl-x-KO MEFs. (A) Embryos were 
isolated from an 11-day pregnant mouse heterozygous for the bc/-x gene. 
Embryonic cells were dissociated and plated in gelatin-coated 12-well 
plates. MEFs were transfected with a plasmid encoding SV40 large T 
antigen to be immortalized. The limiting dilution method was used to 
isolate single clones from each of 10 original embryos. (8) Bcl-XL 
expression in established MEFs was detected by western blot. MEFs from 
embryos 2, 4 and 9 were used as BcI-x knockout, while MEFs from 
embryos 1, 3, 5 and 6 appear to be wild-type and used as controls. The 
expression levels of the other splice variant Bcl-xs was undetected. 
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2.2.4. Gene expression analysis 
Total RNA from two wild-type and two BcI-x-KO MEF cell lines was isolated using 
a RNeasy kit (Qiagen, Germantown, MD). The quality of total RNA was 
confirmed using a 2100 Bioanalyzer (Agilent; Santa Clara, CA). The cRNA was 
generated using a WT Expression Kit (Ambion; Austin, TX) and labeled using a 
GeneChip WT Terminal Labeling Kit (Affymetrix; Santa Clara, CA). Hybridization 
to GeneChip Mouse Gene 1.0 ST Array (Affymetrix) was carried out according to 
the manufacturer's protocol. After array processing and scanning, the resulting 
raw data were summarized and normalized using RMA in Partek Genomics Suite 
6.5 (Partek Inc., S1. Louis, MO) by the University of Louisville Microarray Facility. 
Exon level signals were summarized to gene expression levels using mean 
values. The significance of the changes was determined using ANOVA and 
applying FOR as multiple test correction. 
2.2.5. Cell viability assay 
The propidium iodide (PI) exclusion method was used to determine cell viability. 
MEFs were plated in 48 well tissue culture plates with a cell density of 
approximately 1 x1 04 cells per well 24 hours before treatment with the respective 
apoptotic stimuli. At the indicated time, MEFs were trypsinized and resuspended 
in growth medium containing 1.0 !-Ig/ml PI (Invitrogen). Cell viability was 
measured by PI exclusion method using flow cytometry (FACScalibur, Beckon 
Dickinson; San Jose, CA). The experiments were performed in triplicates. Cell 
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viability of treated cells was presented as percentage of those of untreated 
control cells. 
2.2.6. Caspase 3n assay 
The Sensolyte ® Homogeneous R 110 Caspase 3/7 Assay Kit (AnaSpec; San 
Jose, CA) was used to directly measure caspase 3/7 activity in MEFs. Twenty-
four hours before the treatment, cells were plated in white-walled 96-well plates. 
At the indicated time points, measurement was performed according to the 
manufacturer's protocols. The fluorescence signal (Ex/Em: 496nm/520mn) was 
measured kinetically over 2 hours at an interval of 1 minute by a Gemini EM 
microplate spectrofluorometer (Molecular Devices; Sunnyvale, CA). Data were 
presented as relative fluorescent units versus time (RFU/min). The slope was 
calculated and normalized to those of untreated cells. 
2.2.7. Western blot analyses 
Cell pellets of MEFs were collected and resuspended in RIPA lysis buffer (150 
mM sodium chloride, 1.0% (v/v) Triton X-100, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulphate, and 50 mM Tris, pH 8.0) containing protease inhibitors 
(Complete, Roche; Indianapolis, IN). To remove debris and nuclear materials, 
cells were first sonicated for 30 seconds at 10% amplitude (Sonic Dismembrator, 
Model 500, Fischer Scientific; Hampton, NH) before centrifugation at 13,200 x 
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rpm at 4°C for 10 minutes, and supernatant collected. The protein concentration 
was determined using bicinchoninic acid (BCA) assay (Pierce; Rockford, Il). 
Twenty micrograms of protein sample were loaded on a 4-12% Bis-Tris gel (Bio-
Rad; Hercules, CA) and transferred to PVDF (Millipore; Billerica, MA). The 
membrane filters were incubated in buffer containing 1X PBS, 0.2% (v/v) Tween 
20, and 10% (w/v) nonfat dry milk (BioRad) with appropriate primary antibodies 
at 4°C overnight or at 25°C for about three hours. After three 10 minute washes 
with 1 x PBS/O.2% Tween solution, the membrane filters were then incubated with 
the appropriate peroxidase-coupled secondary antibodies at 4°C overnight or at 
25°C for about three hours. Proteins were detected using the enhanced 
chemiluminescent (ECl) detection system (Pierce, Rockford, Il). 
2.2.8. Immunofluorescence 
Bcl-x-KO MEFs were plated on 18 mm coverslips in a 6-well tissue culture plate 
and allowed to grow overnight. Cells were then transiently transfected with the 
pEGFP-C1 plasm ids expressing the cDNAs of various Bcl-XL mutants using the 
jetPRIME® transfection reagent (Polyplus-transfection SA; Ilikirch, France) 
following the manufacturer's instructions. Forty eight hours post transfection; 
coverslips were transferred into a 12-well cell culture plate and washed twice with 
1.0 ml 1X HBSS (Hanks balanced salt solution). Following 15 minute fixation 
with 0.4 ml 0.4 % paraformaldehyde, cells were washed three times with 1.0 ml 
1X HBSS, and then permeabilized with 0.4 ml 0.2 % TritonX-100 for 15 minutes. 
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After three washes with 1.0 ml incubation solution (0.02 % TritonX-1 00 and 1.5 % 
FBS in 1 X HSSB), cells were incubated with primary antibodies in incubation 
solution for 1 hour at room temperature. Following three 10 minute washes with 
incubation solution, cells were incubated with secondary antibodies for 1 hour at 
room temperature, and again washed three times with incubation solution. The 
coverslips were then immersed in mounting medium (Oako, Carpinteria, CA), put 
on slides, and sealed with nail polish. The fluorescence images were visualized 
and acquired using a PlanApo 60x, 1.40 NA oil immersion objectives on a Nikon 
Eclipse Ti (Melville, NY) confocal microscope according to the manufacturer's 
protocol. 
2.2.9. Measurement of cytoplasmic and ER Ca2+ concentrations 
Cytoplasmic and ER Ca2+ concentrations measurement data were collected by 
the Carl White laboratory from the Rosalind Franklin University of Medicine and 
Science, North Chicago. For cytoplasmic [Ca2+], MEFs cultured on glass 
coverslips were loaded with 2 IJM fura-2AM (Invitrogen) and incubation at room 
temperature for 45 minutes and mounted in a recording chamber positioned on 
the stage of an inverted microscope (IX71; Olympus). Fura-2 was alternately 
excited at 340 nm and 380 nm and the emitted fluorescence filtered at 510 nm 
collected and recorded using a CCO-based imaging system running SimplePCI 
software (Hamamatsu; Sewickley, PA). The chamber was continuously perfused 
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with HBSS (pH 7.4) at room temperature. A rapid solution changer was used to 
switch the composition of the solution bathing the cells under study. 
To measure ER [Ca2+], MEFs were loaded with mag-fura-2AM (5IJM) for 60 
minutes at room temperature and perfused with intracellular-like medium (ICM) 
containing: 125 mM KCI, 19 mM NaCI, 10 mM Hepes, 1 mM EGTA (pH 7.3 with 
KOH) and permeabilized by a 20-30 minute exposure to ICM containing 20 IJM 
digitonin. After 20-30 minute incubation in ICM, stores were Ca2+-loaded by 
switching to ICM solution with free [Ca2+] adjusted to 200 nM and 1.5 mM 
MgATP. To induce Ca2+ release, InsP3 was applied in the same Ca2+-containing 
ICM solution but without MgATP to prevent reuptake. Data were acquired as 
described for fura-2 and ratiometric data (R) and were normalized to basal store-
depleted levels (Ro). For experiments using flash photolysis of caged-lnsP3, cells 
were loaded with the membrane-permeable caged InsP3 compound ci-lnsPyPM 
(0-2, 3-0-isopropyl idene-6-0-(2 -n itro-4, 5-dimethoxy )benzyl-myo-i nositol 1 ,4,5-
trisphosphate-hexakis(propionoxymethyl) ester; SiChem, Bremen, Germany) by 
incubation with 1 IJM for 60 minutes at room temperature. InsP3 was photo-
released by brief pulses (250 ms) of UV light (350-400 nm) delivered uniformly 
throughout the image field. The application of UV pulses precluded the use of 
fura-2 as a [Ca2+] indicator, therefore, cells were co-loaded with the longer 
wavelength dye fluo-2AM (5 IJM; TEFLabs, Inc., Austin, TX) and fluorescence 
data (F) normalized to basal levels (Fo). 
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2.2.10. Statistical analysis 
All experiments were performed in triplicates and each experiment was carried 
out at least three times. Statistical analysis was performed using the student t-




2.3.1. Bcl-x knock-out does not cause compensatory changes in 
expression levels of other Bcl-2 proteins. 
As mentioned earlier, BcI-xL is generated from alternative splicing of the Bcl-x 
[12]. Massive cell death has been found in a variety of tissues in the Bcl-x-
deficient mouse, which dies at embryonic day 13, therefore reflecting its 
important role in development [80]. To investigate the function of endogenous 
BcI-xL protein in apoptosis regulation, we established MEFs deficient in Bcl-XL 
expression (Bcl-x-KO) as described earlier (Figure 2.1). As reduced expression 
of the anti-apoptotic Bcl-2 has been shown to affect the expression of other 
apoptotic regulators [111], we determined whether bcl-x gene knock out will 
cause changes in expression levels of other genes, particularly those of the Bcl-2 
protein family. To this purpose, microarray analysis was carried out in two BcI-x-
KO (lines 4 and 9) and two wild-type (lines 3 and 6) MEFs. Gene expression 
levels were determined and the fold change between Bcl-x-KO and wild type 
MEFs were determined (Table 2.1). In this assay (GeneChip® Mouse Gene 1.0 
ST Array), analysis of multiple probes on different exons was summarized into an 
expression value representing all transcripts from the same gene. 
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Table 2.1. Changes in mRNA expression of Bcl-2 genes induced by Bcl-x 
deficiency were determined by microarray analysis. (A) Data are 
represented as fold-changes in mean value of mRNA levels of the anti-
apoptotic Bcl-2 proteins and the multidomain pro-apoptotic Bcl-2 proteins 
in two wild-type and two Bcl-x-KO MEFs. (B) BH3-ony Bcl-2 proteins did 
not show changes in mRNA expression levels between wild-type and BcI-
x-K~ MEFs. Negative values indicate down-regulation. 
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As the Bcl-x-deficient mouse was generated by homologous recombination, 
some exons in the targeted bcl-x gene were still intact. By this approach, Bcl-x 
mRNA was still detectable in BcI-x-deficient cells, and bc/-x mRNA level in Bcl-x-
KO MEFs was significantly reduced compared with that in wild-type MEFs, 
validating the disruption of intact BcI-x mRNA in Bcl-x-KO MEFs. Knocking out of 
the BcI-x gene does not cause significant changes in mRNA expression of other 
Bcl-2 proteins, including anti-apoptotic BcI-2 proteins (Table 2.1A), pro-apoptotic 
multi domain Bcl-2 proteins (Table 2.1A) and pro-apoptotic BH3-only Bcl-2 
proteins (Table 2.1 B). Western blot analysis was performed to further validate 
that Bcl-x-deficiency does not cause significant changes in BcI-2 protein 
expression (Figure 2.2). These results indicate that alterations in cellular 
apoptotic signaling in response to apoptotic stimuli in Bcl-x-KO MEFs is attributed 
to BcI-Xl deficiency, therefore providing an excellent cell system to study the 














Figure 2.2. Bcl-x deficiency does not cause compensatory changes in 
expression of other Bcl-2 proteins . Expression of Bcl-2 proteins in the 
indicated MEFs was determined by western blot analysis . WT #1 , cell line 
3; WT #2, cell line 6; KO #1 , cell line 9; KO #2, cell line 
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2.3.2. Endogenous Bcl-xL modulates cellular responses to apoptosis 
To investigate the functional activity of endogenous Bcl-XL in apoptotic signaling, 
two wild-type (cell lines 3 and 6) and two Bcl-x-KO (cell lines 4 and 9) MEFs were 
exposed to death causing agents with diverse mechanisms to induce apoptosis 
including the topoisomerase inhibitor etoposide (5.0 IJM), the transcriptional 
inhibitor actinomycin D (0.2 IJg/ml), the DNA intercalating agent doxorubicin (1.0 
IJM), the protein kinase inhibitor staurosporine (5.0 nM), and the oxidative stress 
inducer H202 (0.4 mM). When wild-type and BcI-x-KO MEFs were treated with all 
of these agents, there was significantly more cell death in Bcl-x-KO compared to 
wild type MEFs, except that the protection against actinomycin D in wild type 
cells seems to be transient (Figure 2.3A). As BcI-XL is the major splicing product 
of the BcI-x gene in MEFs, higher sensitivity of Bcl-x-KO MEFs to apoptotic 
insults suggests that endogenous Bcl-XL is able to protect cells against these 
apoptotic insults. To confirm further that endogenous Bcl-XL is able to inhibit 
apoptosis, caspase 3/7 activity was measured in all the wild-type and Bcl-x-KO 
MEFs treated with apoptotic agents. As shown in Figure 2.3B, caspase 3/7 
activity was enhanced in BcI-x-KO MEFs to higher levels than that in wild-type 
MEFs upon treatment with all apoptotic insults. The increase in caspase 317 
activity correlated with the increase in cell death, suggesting that endogenous 
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Figure 2.3. Endogenous Bel-XL modulates cellular response to different 
apoptotic stimuli. (A) Apoptosis was induced by the indicated apoptosis 
agents: etoposide (5.0 jJM); doxorubicin (1.0 jJM); actinomycin D (0.2 
jJg/ml); staurosporine (5.0 nM); or hydrogen peroxide (0.4 mM). 8c1-x-KO 
MEFs were more sensitive to these reagents. Data represent mean ± 
standard deviation of three independent experiments performed in 
triplicate. (B) Caspase 3/7 activity was measured 12 hours following 
treatment with etoposide, doxorubicin, or staurosporine or 9 hours after 
actinomycin D and H202 treatment using fluorometric assay. Values are 
normalized to the values obtained in the untreated control cells. Data are 
shown as mean ± S.D. of three independent triplicate experiments. 
**P<0.01; ***P<0.001. 
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To ensure that enhanced apoptosis observed in Bcl-x-KO MEFs was due to 
deficiency in BcI-XL protein expression only, BcI-XL cDNA was re-expressed in 
Bcl-x-KO MEFs (cell line 9) to obtain cells with different BcI-XL levels. Three cell 
lines were selected; cell line H (high) with Bcl-XL expression level higher than the 
endogenous BcI-XL level, cell line M (medium) with BcI-XL expression level 
comparable to the endogenous level, and cell line L (low) with expression level 
lower than the endogenous BcI-XL level (Figure 2.4A). When cells were treated 
with different death stimuli described previously in Figure 2.3A, expression of Bcl-
XL in BcI-x-KO MEFs was able to restore the BcI-x-KO MEFs' resistance to 
apoptosis (Figure 2.4B). Importantly, BcI-XL protected cells against apoptotic 
stimuli in a BcI-XL dose-dependent manner, further substantiating that increased 
sensitivity of BcI-x-KO MEFs to death stimuli is caused by the lack of 
endogenous Bcl-xL expression (Figure 2.4B). The caspase 3/7 activity of different 
cell lines following treatment with the apoptotic agents was measured, and the 
correlation between caspase 3/7 activities with levels of cell death was observed, 
providing more evidence of the involvement of endogenous BcI-XL in apoptotic 
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Figure 2.4. Reexpression of Bcl-xL in Bcl-x-KO MEFs restores resistance to 
apoptotic stimuli in a Bcl-xL dose-dependent manner. (A) Bcl-XL was 
reexpressed in BcI-x-KO MEFs. Western blot analysis was used to 
determine Bcl-XL expression levels. (B) Viability of the indicated MEFs 
was measured in the presence of the indicated apoptotic stimuli. Data 
represent mean ± standard deviation of three triplicate independent 
experiments. (C) Caspase 3/7 activity was measured under the conditions 
described in Figure 2.3B. Values are normalized to the values of 
untreated control cells. Data show mean ± standard deviation of three 
independent experiments performed in triplicate. *P<O.05; **P<O.01; 
***P<O.001. 
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2.3.3. Targeting Bcl-xL mutants specifically to the cytosol, the ER, or the 
mitochondria 
To investigate the anti-apoptotic functions of Bcl-XL localized on different 
intracellular organelles, we constructed Bcl-xL mutants that either lacked the 
membrane targeting sequence, or contained an ER-specific or a mitochondrial-
specific membrane targeting sequences. The carboxyl-terminal transmembrane 
sequence of BcI-XL was deleted, and deleting this sequence specifically confines 
BcI-XL to the cytosol (Bcl-xL-~C). The carboxyl-terminal transmembrane region of 
BcI-xL was replaced by the cytochrome b5 (cb5) membrane targeting sequence 
which directs BcI-xL specifically to the ER membrane, or the membrane targeting 
sequence of the Listeria protein ActA, which specifically targets BcI-XL to 
mitochondria (Figure 2.5A). The same targeting sequences have been used 
previously to target both anti- and pro-apoptotic BcI-2 proteins to a specific 
organelle [105, 112, 113]. 
To confirm subcellular localization of BcI-XL mutant proteins, cDNAs of the 
respective Bcl-xL mutants were subcloned into the plasmid containing the green 
fluorescent protein (EGFP-C1), and confocal microscopy was used to examine 
their subcellular localization. GFP-tagged Bcl-xL mutants were transiently 
expressed in BcI-x-KO MEFs. The mitochondrial protein Tom20 served as a 
mitochondrial maker and the ER protein cal reticulin was selected as an ER 
marker. While the intracellular localization of GFP-tagged BcI-xL -ActA 
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superimposed with that of Tom20, the staining patterns for GFP-8cl-xL-ActA and 
calreticulin were clearly distinct (Figures 2.58). 
In contrast, GFP-tagged 8cl-xL-cb5 was completely targeted at the ER with its 
fluorescence superimposed with that of calreticulin but not Tom20 fluorescence, 
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Figure 2.5. Generation of mitochondrially targeted and ER-targeted Bcl-xL 
mutants. (A) Scheme of the Bcl-XL mutants. The carboxyl-terminal 
transmembrane domain of Bcl-XL was deleted (~C) and replaced with the 
mitochondria-targeting sequence of ActA or the ER-targeting sequence of 
cb5. (B) The indicated GFP and BcI-xL fusion proteins were transiently 
expressed in BcI-x-KO MEFs. The mitochondrial protein Tom20 was 
detected as organelle marker, while the ER protein calreticulin was used 
as ER marker. The fluorescence was visualized by confocal microscopy. 
Scale bar, 10 j..Im 
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2.3.4. Mitochondrially targeted Bcl-XL prevents apoptosis more effectively 
than ER-targeted Bcl-xL 
To investigate whether BcI-xL proteins targeted at specific organelles mediate 
different apoptotic signaling pathways, the mutant BcI-xL proteins were 
expressed in BcI-x-KO MEFs (cell line 9) at levels comparable to that of 
endogenous Bcl-xL (Figure 2.6A). BcI-x-KO MEFs expressing different BcI-xL 
mutants were treated with various death reagents (etoposide, doxorubicin, 
actinomycin 0, staurosporine, and H202), and cell viability determined. 
Expression of BcI-xL-ActA in BcI-x-KO MEFs provided protection against all 
apoptotic reagents at the level comparable with that of wild-type BcI-xL (Figure 
2.6B). In contrast, both Bcl-xL lacking membrane-anchoring region (Bcl-xL -dC) 
and ER-Iocalized BcI-xL (Bcl-xL -cb5) failed to protect cells against any of the 
death stimuli examined (Figure 2.6B). These data suggest that mitochondrial 
localization is an absolute requirement for Bcl-xL to be protective in various 
apoptotic paradigms. 
This was further confirmed by the experiments in which caspase 3/7 activity was 
measured in response to cell death stimuli. Caspase 3/7 activity of BcI-x-KO 
MEFs expressing Bcl-xL -cb5 or Bcl-xL -dC was higher than that of cells 
expressing BcI-xL-ActA or wild-type Bcl-xL (Figure 2.6C). 
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Figure 2.6. Mitochondrially targeted Bcl-XL inhibits apoptosis more 
efficiently than Bcl-XL targeted at the ER. (A) The indicated BcI-xL 
mutants were expressed in BcI-x-KO MEFs at the levels similar to the 
endogenous Bcl-XL level. Bcl-xL expression was determined by Western 
blot analysis. (B) MEFs expressing different BcI-xL mutants were treated 
with either 5.0 j..IM etoposide, 1.0 j..IM doxorubicin, 0.2 j..Ig/ml actinomycin 
D, 5.0 nM staurosporine or 0.4 mM H20 2, and cell viability was measured. 
The data depict mean ± standard deviation of three independent 
experiments. (C) Caspase 3/7 activity was measured as described in 
Figure 2.3B. Values are normalized to those of untreated cells. All data 
shown are the means ± standard deviation of experiments independently 
performed three times. *P<0.05; **P<0.01; ***P<0.001. 
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2.3.5. ER-targeted Bcl-xL modulates ER Ca2+ homeostasis 
Previously, Li et al. [107] demonstrated that overexpression of Bcl-XL lowers the 
steady-state [Ca2+] within ER stores ([Ca2+]ER) and affects intracellular Ca2+ 
([Ca2+]j) signaling by modulating channel activities of the ER Ca2+ release 
channel inositol trisphosphate (InsP3) receptor [107, 114]. Here we investigated 
whether organelle-targeted BcI-XL proteins influenced InsP3-dependent [Ca2+]j 
signaling. To investigate whether organelle-targeted Bcl-xL proteins influenced 
InsP3-dependent [Ca2+]j signaling, [Ca2+]j was monitored in response to an 
increase in intracellular [lnsP3] evoked by flash photolysis of caged InsP3 (Figure 
2.7 A). Maximal InsP3 uncaging and/or receptor activation in these cells was 
produced by UV pulses of 250 ms duration. This level of InsP3 evoked larger 
[Ca2+] transients in Bcl-x-KO MEFs compared with wild-type MEFs (Figures 2.7 A 
and 2. 7B). Reexpression of Bcl-xL in BcI-x-KO MEFs localized at the ER but not 
at mitochondria restored InsP3-evoked Ca2+ signal to the level observed in wild-
type MEFs (Figures 2.7A and Figure 2.7B). These data are consistent with 
previous studies showing that BcI-XL overexpression reduces ER Ca2+ store 
content and thus the magnitude of ER Ca2+ release in response to maximailnsP3 
stimulation [107]. 
As steady-state [Ca2+]ER is determined by the balance between ER Ca2+ leakage 
and Ca2+ uptake by sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), 
[Ca2+]ER was further evaluated by monitoring [Ca2+]j in response to inhibition of 
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ER Ca2+ uptake by the SERCA inhibitor cyclopiazonic acid (CPA) in the absence 
of external Ca2+. A smaller Ca2+ response was evoked by cyclopiazonic acid in 
wild-type MEFs compared with BcI-x-KO MEFs (Figure 2.7C). The ER Ca2+ 
release was quantified by calculating the integral of the [Ca2+]j transient since the 
total released [Ca2+] more closely reflects the steady-state store content (Figure 
2.70). Again, the phenotype of wild-type MEFs was observed only in Bcl-x-KO 
MEFs expressing Bcl-XL localized at the ER but not Bcl-XL localized at the 
mitochondria. To confirm further the effects of organelle-targeted BcI-XL on ER 
. Ca2+ store, direct measurements of [Ca2+]ER were also carried out using the low 
affinity Ca2+ indicator Mag-fura-2. Since Mag-fura-2 compartmentalizes in the ER 
as well as in the cytoplasm, the plasma membrane was permeabilized to remove 
cytoplasmic indicator, and the cells were perfused with a Ca2+ free solution to 
allow passive depletion of ER Ca2+ store [115]. After equilibration, Ca2+ uptake 
into the store was induced by switching the perfusate to the solution containing 
1.5 mM MgATP and 200 nM free [Ca2+]. Once a steady-state had been reached, 
the solution was switched to one containing saturating [lnsP3] (10 !-1M) without 
MgATP [116]. 
As depicted in Figure 2.7E, application of InsP3 induced depletion of the ER Ca2+ 
store. This was a unidirectional measure of Ca2+ flux since the MgATP required 
for SERCA pump function was not present during InsP3 addition. Consistent with 
the previous experiments, BcI-XL deficiency elevated steady-state Ca2+ in the ER 
that was rescued by Bcl-XL expression on the ER (Figures 2.7E and 2.7F). In 
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addition, the magnitudes of Ca2+ release evoked by saturating [lnsP3] mirrored 
the filling state of the ER [106] (Figure 2.7G), and are in agreement with the data 
from intact cells (Figure 2.7A). Taken together, these data show that expression 
of ER-targeted BcI-xL produces phenotypes that are entirely consistent with our 
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Figure 2.7. ER-Iocalized Bel-XL but not mitochondrially targeted Bcl-XL 
modulates ER Ca2+ homeostasis. (A) Representative [Ca2+]j responses 
in fluo-2AM-loaded cells in response to flash photolysis of caged- InsP3. 
(B) Summary bar graphs demonstrate the amplitude of [Ca2+]j change 
after InsP3 uncaging shown in A. Data represent the mean ± SEM 
amplitude of 31-66 cells pooled from at least three independent coverslip 
(*P<0.05; ANOVA). (C) The Ca2+ content of the ER was indirectly 
assessed by monitoring [Ca2+]j measured by fura-2 in response to acute 
inhibition of ER Ca2+ uptake by cyclopiazonic acid (CPA; 10 jJM). 
Representative traces of the indicated cell lines are shown. (0) Bar 
graphs summarizing the total released [Ca2+] assessed by measuring the 
area under the Ca2+ transient evoked by CPA, (Area Under Curve; AUC). 
Data represent the mean ± SEM of at least 50 cells pooled from at least 
three separate trials (*P<0.05; ANOVA). (E) Representative recordings of 
[Ca2+]ER in permeabilized cells during store filling initiated by addition of 
200 nM Ca2+ and 1.5 mM MgA TP and store depletion by the application of 
10 jJM InsP3. Each trace represents mean of 15-20 cells in a single image 
field. (F-G) Summary data (mean ± SEM) for 116-146 cells pooled from at 
least 3 independent trials. The steady-state uptake capacity of [Ca2+]ER 
after store filling is shown in F and the amplitude of [Ca2+]ER release in the 
presence of InsP3 is shown in G; (*P<0.05; ANOVA). 
69 
2.3.6. Endogenous Bcl-Xl is essential for anti-apoptotic activities of ER 
localized Bcl-Xl. 
Overexpressing ER-Iocalized Bcl-Xl in the breast cancer line MCF-7 and Rat-1 
fibroblasts has been shown to exhibit broader anti-apoptotic activities than Bcl-xl 
targeted at mitochondria [113]. To explore the discrepancy between this finding 
and our observations that ER-Iocalized BcI-xl failed to protect against apoptosis 
in BcI-x-KO MEFs (Figure 2.6), Bcl-xl-cbS was stably expressed in wild-type and 
BcI-x-KO MEFs at the similar levels, and uncloned populations of cells were 
obtained (Figure 2.8A). MEFs were then exposed to various death stimuli and 
cell viability was measured. While Bcl-xl-cbS did not possess any anti-apoptotic 
activities in BcI-x-KO MEFs, expressing the same protein in wild-type MEFs 
markedly protected against cell death in all apoptotic paradigms examined, thus 
indicating that anti-apoptotic activities of Bcl-xl targeted at ER depends on 
endogenous BcI-xl (Figure 2.8B and 2.8C). Examination of caspase 3/7 activity 
further confirmed the indispensible role of endogenous Bcl-Xl in the anti-
apoptotic function of ER-targeted Bcl-xl (Figure 2.80 and 2.8E). 
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Figure 2.8. Anti-apoptotic activities of ER-targeted Bcl-XL depend on 
endogenous Bcl-xL. (A) Bcl-XL was stably expressed in wild-type and BcI-
x-K~ MEFs, and expression of BcI-XL in uncloned cell populations was 
determined by western blot analysis. Note that the molecular weights of 
BcI-XL -cb5 and endogenous BcI-XL are different. (B) Wild-type MEFs with 
or without BcI-xL-cb5 expressions were treated with the indicated death 
stimuli and cell viability was determined. The data depict mean ± standard 
deviation of three independent experiments. *P<O.05; **P<O.01; 
***P<O.001. (C) The indicated BcI-x-KO MEFs were treated with the 
apoptotic stimuli as shown in (B) and their effects on cell survival were 
examined. Mean ± standard deviation of three independent experiments 
are shown. (0) Upon treatment with etoposide, doxorubicin and 
staurosporine for 12 hours, actinomycin D for 7 hours and H202 for 9 
hours, caspase 3/7 activity of various wild-type MEFs was determined 
using a fluorometric assay. Each experiment was performed in triplicate, 
and mean ± standard deviation of three independent experiments are 
shown. *P<O.05; **P<O.01. (E) Different Bcl-x-KO MEFs were treated with 
the indicated apoptotic stimuli, and caspase 3/7 activity was measured. 




Anti-apoptotic Bcl-xL is localized at both mitochondria and the ER [113]. At the 
mitochondria, Bcl-xL functions to prevent OMM permeabilization during apoptotic 
stress, and also plays an important role in optimizing mitochondrial bioenergetic 
function through interactions with various membrane proteins [117-119]. Previous 
work demonstrate that BcI-xL functioned at the ER to modulate basal Ca2+ 
signaling and steady-state ER Ca2+ store content by interacting with the InsP3 
receptor [107, 114]. Collectively, these studies reveal that Bcl-xL has diverse 
physiological roles that appear to depend on its intracellular localization. In this 
specific aim, we sought to understand better the relationship between 
intracellular localization of Bcl-xL and apoptosis protection. Our approach was to 
generate a BcI-xL-deficient model in which Bcl-xL targeted at different organelles 
was expressed and its effects on apoptotic sensitivity were examined. MEFs 
deficient in Bcl-xL expression were established from bc/-x heterozygous mice. 
Although alternative splicing of Bcl-x generates Bcl-xL and BcI-xs, BcI-xL is the 
major splicing product in MEFs (Figure 2.1). 
Unlike reducing BcI-2 expression in LNCaP cells [111], knocking out BcI-xL 
expression in MEFs failed to induce compensatory changes in other Bcl-2 family 
members (Figure 2.2 and Table 2.1). As expected, MEFs deficient in BcI-xL 
expression were more sensitive to various death stimuli compared with wild-type 
MEFs. Furthermore, reexpression of wild-type Bcl-xL in Bcl-x-KO MEFs restored 
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cellular protection against apoptotic insults in a Bcl-XL dose-dependent fashion 
(Figure 2.3). These data demonstrate the validity of this experimental model. Bcl-
2 protein are localized at both the mitochondria and the ER [101]. 
To distinguish between the functions of BcI-XL localized at different organelles, 
we targeted BcI-XL to a particular organelle by replacing the carboxyl 
transmembrane region of Bcl-xL with known organelle targeting sequences. As 
mitochondria and the ER have been proposed to interact dynamically with each 
other inside cells [120], it is challenging to exclusively target proteins to a given 
organelle. Unlike previous studies in which anti-apoptotic BcI-2 proteins targeted 
at a particular organelle were overexpressed [112, 113], stable cell lines in the 
current study were carefully selected so that mitochondria- or ER-Iocalized Bcl-xL 
was expressed at levels comparable to that observed in wild-type MEFs (Figure 
2.6). It was expected that lower expression levels would also help ensure more 
exclusive targeting. Thus, the distinct patterns in the intracellular residence of 
targeted BcI-xL proteins are sufficient to reveal the distinctive roles of BcI-xL 
localized on different organelles. 
We observed that in the BcI-x-KO background mitochondrially localized BcI-xL 
functioned as effectively as wild-type protein in inhibiting apoptosis. On the other 
hand, ER-targeted Bcl-XL failed to exhibit any anti-apoptotic activity in BcI-x-KO 
MEFs (Figure 2.6). Intriguingly though, Bcl-XL expression at the ER in BcI-x-KO 
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MEFs completely rescued abnormal Ca2+ signaling phenotypes (Figure 2.7). It is 
well documented that steady-state ER Ca2+ correlates closely with apoptotic 
sensitivity increased ER Ca2+, increased apoptosis, and vice versa. Here, 
increased ER Ca2+ content sensitizes cells to apoptotic stimuli by providing a 
greater pool of releasable Ca2+ that enhances mitochondrial Ca2+ uptake and 
susceptibility to OMM permeabilization [102, 104]. Both overexpression of BcI-2 
and Bcl-XL have been shown to lower ER store Ca2+ [107,114,121, 122]. We 
reasoned that the discrepancy could be accounted for if BcI-XL localized at other 
organelles was essential for it to be anti-apoptotic at the ER. 
Consistent with this reasoning, expression of ER-targeted Bcl-XL was fully 
effective in protecting against apoptosis in wild-type MEFs (Figure 2.8). Thus, our 
current study provides molecular evidence that the protective function of Bcl-XL at 
the ER requires BcI-XL localization at other cellular compartments. We speculate 
that this compartment is mitochondria, but further studies are needed to assess 
exactly how mitochondrially targeted Bcl-XL is required to sense physiological 
changes conferred by BcI-XL at the ER, and how these signals are translated into 
apoptotic protection. It is possible that mitochondrial BcI-XL is required to facilitate 
ER-to-mitochondrial Ca2+ transfer, and enhanced mitochondrial bioenergetics 
subsequently renders cells to better withstand apoptotic challenges. In summary, 
we have developed BcI-xL-deficient MEFs suitable for the study of Bcl-XL-
regulated apoptotic pathways. We demonstrate that localization at mitochondria 
is necessary for endogenous levels of BcI-XL to provide apoptotic protection. 
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Furthermore, we show that localization of Bcl-XL at the ER is required for normal 
Ca2+ homeostasis, but that targeting Bcl-xL at the ER only provides increased 
apoptotic protection if BcI-xL is also present at other organelles. 
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CHAPTER III 
ENDOGENOUS BCl-XL MODULATES CEllULAR RESPONSE TO 
OXIDATIVE STRESS-INDUCED APOPTOSIS 
3.1. Introduction 
Apoptosis is regulated by the Bcl-2 family of proteins which can be either pro-
apoptotic or anti-apoptotic [3, 44, 45]. In healthy cells, BcI-XL binds to BH3-only 
BcI-2 proteins and/or multidomain Bax and Bak, inhibiting their pro-apoptotic 
activities. In dying cells, BH3-only Bcl-2 proteins are activated. Activated BH3-
only Bcl-2 proteins then either interact with Bax and Bak or bind to anti-apoptotic 
BcI-2 proteins releasing them from their complexes with Bax and Bak, thus 
activating Bax and Bak. Activated Bax and Bak assemble permeation channels 
on OMM, releasing apoptogenic factors including cytochrome c and Diablo/Smac 
from the IMS of the mitochondria into the cytosol where they promotes activation 
of caspase cascade and apoptosis [54, 75]. Dysregulation of apoptotic signaling 
pathways has been associated with the development of many diseases including 
cancer, infections and neurodegeneration [1, 3]. 
Generation of reactive oxygen species (ROS) has also been implicated in 
neurodegenerative diseases such as Alzheimer disease and Parkinson's disease 
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[13], and in cancer [14]. The oxidative stress inducer H202 causes both apoptosis 
and necrosis. Mild to moderate levels of H20 2 cause apoptosis while higher levels 
induce necrosis [93]. The mechanisms through which oxidative stress inducers 
such as H202 promote apoptosis are not completely understood. However, 
recent evidence indicates that BcI-2 proteins are involved in regulating oxidative 
stress-induced apoptosis [123]. Overexpressing Bcl-2 has been shown to 
suppress oxidant-induced apoptosis probably by inhibiting lysosomal membrane 
rupture [124, 125]. Several BH3-only BcI-2 proteins have also been found to be 
involved in H20 2-induced apoptosis [126-128]. Nonetheless, how anti-apoptotic 
BcI-2 proteins coordinate with pro-apoptotic Bcl-2 proteins to regulate apoptosis 
remains unclear. 
Here, we systematically explored the role of BcI-2 proteins in the regulation of 
H202-induced apoptosis. I show that endogenous BcI-XL inhibits cell death 
induced by H20 2. Furthermore, upon H20 2 exposure, Noxa up-regulation and 
subsequent Mcl-1 expression decrease are essential for apoptosis. Our findings 
provide evidence that both anti- and pro-apoptotic Bcl-2 proteins modulate 
apoptotic signaling triggered by oxidative stress. 
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3.2. Materials and Methods 
3.2.1. Reagent and cell culture 
H202 was purchased from Sigma. Propidium iodide (PI) was obtained from 
Molecular Probes. The Lipofectamine ™ RNAiMAX and Lipofectamine ™ 2000 
reagents were obtained from Invitrogen. Mcl-1 and Bcl-XL small interfering RNAs 
(siRNAs) were obtained from Santa Cruz Biotechnology, while caspase 3/7 
assay kit was purchased from AnaSpec. Antibodies used for western blot 
analysis were anti-BcI-xS/L S-18 pAb (polyclonal antibody) and anti-BcI-2 mAb 
(monoclonal antibody) from Santa Cruz Biotechnology, anti-!3-actin mAb from 
Sigma, anti-McI-1 pAb from Epitomics, anti-BcI-w pAb from Cell Signaling 
Technology, peroxidase-conjugated goat anti-(rabbit IgG) and peroxidase-
conjugated goat anti-(mouse IgG) from Thermo Fisher Scientific. 
MEFs studied here were deficient in BcI-XL (BcI-x-KO), Mcl-1 (Mcl-1-KO), or Noxa 
(Noxa-KO). BcI-x-KO MEFs expressing Bcl-XL [BcI-XL(H), BcI-XL(M) and BcI-XL(L)] 
were also used. MEFs were cultured in DMEM (Mediatech; Manassas, VA) 
supplemented with 10% FBS (Gemini; West Sacramento, CA), 100 U/ml 
penicillin (Mediatech), and 100 ~g/ml streptomycin (Mediatech) in an incubator 
with 95% humidity and 5% C02 at 37 DC. 
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3.2.2. Plasmid construction 
The cDNAs of murine anti-apoptotic BcI-2 protein Mcl-1, and a panel of ten pro-
apoptotic BH3-only BcI-2 proteins, including Bim, tBid, Puma, Bad, Bik, Noxa, 
Bnip3, Nix, Hrk, and Bmf were subcloned into the retroviral expression vector 
pBABE with the enhanced green fluorescent protein (EGFP) serving as a marker 
expressed from an internal ribosomal entry site (IRES) [pBABE-IRES-EGFP]. 
The pBABE-IRES-EGFP plasmid and plasm ids containing cDNAs for the BH3-
only BcI-2 protein of interest were first digested with the appropriate restriction 
enzymes. DNA fragments of the vector (pBABE-IRES-EGFP) and the respective 
cDNAs of interest were purified after resolving by agarose gel electrophoresis 
and ligated using the Promega ligation reagent (Promega) at 16°C overnight. 
The ligated product was then used for Escherichia coli (~ colt) transformation 
reaction with NEB 5aF'fl competent cells (New England Biolabs).Transformed ~ 
coli was spread on LB plates containing carbenicillin antibiotics. These plates 
were also incubated overnight at 37°C for colonies to grow. Then, single ~ coli 
colonies were selected, and inoculated in 2 ml LB medium also supplemented 
with carbenicillin. Inoculum was then incubated at 37°C for 6-8 hours. 
Plasmid DNA of the inoculum was purified using miniprep kit (GenScript). It was 
then digested with EcoRI and BamHI restriction endonucleases (REs), and 
digested plasmid DNA was analyzed by agarose gel electrophoresis to examine 
the presence of DNA fragments with the size of the respective DNA of interest. 
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Sequence analysis was performed to determine the exact DNA composition of 
the respective pro-apoptotic BH3-only Bcl-2 proteins. Once the exact DNA 
composition was determined, the rest of the inoculum in the 2 ml LB media was 
transferred into a flask containing 400 ml LB media also supplemented with 
carbenicillin, and further incubated at 37 DC overnight. Plasmid DNA in the 
culture was purified using the cesium chloride (CsC/) ultra-centrifugation method. 
DNA sequence of the purified plasm ids was again confirmed. The purified 
plasm ids were then used for transfection and retroviral infection experiments. 
3.2.3. Production of retroviral supernatants 
The packaging cell line 293T was transfected with the plasmid carrying the 
respective gene of interest and the retroviral helper plasmids pMDG2.0 and 
pUVMC using the Lipofectamine 2000 reagent as a lipid transfection milieu. 
About 106 cells were plated in 6 cm dish and allowed to grow to confluency. For 
cDNAs of each of ten BH3-only Bcl-2 proteins, 5 I-1g of plasm ids DNA and 5 I-1g of 
retroviral packaging plasmids [pUVMC (2.5 I-1g) and pMDG2.0 (2.5 I-1g)] were 
diluted in 0.5 ml of Opti-MEM medium (Invitrogen). In a separate test tube, 20 1-11 
of lipofectamine 2000 reagent was diluted in 0.5 ml of Opti-MEM medium. Both 
samples were incubated at room temperature for 5 minutes, mixed together and 
incubated for another 20 minutes. After 20 minute incubation, each sample was 
added to the T293 cells and incubated at 37 DC in a 5% CO2 incubator for 4-6 
hours. Media were replaced with 3 ml fresh media per dish. Cells were incubated 
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at 37 DC in a 5% CO2 incubator for 48-72 hours prior to testing for transgene 
expression. Media containing retroviral supernatant was collected 48-72 hours 
post transfection. Ten !-Ig/ml of polybrene (Sigma) was added to the retroviral 
supernatants to increase infection efficiency. The respective retroviral 
supernatants were used to infect various MEFs. 
3.2.4. Cell viability 
Cell viability was determined by PI exclusion method using flow cytometry 
analysis (FACScalibur, Beckon Dickinson; San Jose, CA). MEFs were plated in 
48 well tissue culture plate at a density of approximately 104 cells per well. MEFs 
were treated with different apoptotic stimuli or infected with retroviral supernatant 
containing the respective pro-apoptotic BH3-only BcI-2 proteins. After the 
indicated time, MEFs were collected, 1.0 !-Ig/ml of PI was added and cell viability 
was measured. 
3.2.5. Caspase 3/7 activity 
We used the Sensolyte® Homogeneous R110 Caspase 3/7 Assay Kit (AnaSpec) 
to measure caspase 3/7 activity. MEFs were plated at a density of approximately 
2.5 x 103 cells per well in a white-walled 96-well tissue culture plates and allowed 
to grow overnight. Caspase 3/7 activity was determined 9 hours following 
treatment with H20 2 according to the manufacturer's protocols. The slope of 
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fluorescence increase was calculated and normalized to that of untreated cells, 
and data were presented as the relative fluorescence unit versus time (RFU/min). 
3.2.6. Western blot analysis 
Cell pellets were collected and whole cell Iysates generated by suspending cells 
in RIPA lysis buffer [150 mM sodium chloride, 1.0% (v/v) Triton X-100, 0.5% 
sodium deoxycholate, 0.1 % sodium dodecyl sulphate, and 50 mM Tris, pH 8.0] 
containing protease inhibitors (Complete, Roche; Indianapolis, IN). Total protein 
concentration was determined using the BCA assay (Pierce; Rockford, IL). Equal 
amount (20 /-lg) of protein per sample was loaded on a 4-12% Bis-Tris gel (Bio-
Rad; Hercules, CA), transferred to PVDF (Millipore; Billerica, MA) and used to 
determine the expression of the respective proteins, with their appropriate 
primary and secondary antibodies indicated. 
3.2.7. siRNA transfection 
MEFs (BcI-x-WT, Bcl-x-KO, McI-1-WT, and McI-1-KO) were plated in 6-well 
tissue culture plates at a cell density of 2 x105 per well or in 48-well tissue culture 
plates with 1x104 cells in each well 24 hours before transfection. Mcl-1 siRNA 
and BcI-XL siRNA with a final concentration of 10 nM were transfected into MEFs 
with lipofectamine RNAiMax reagents (Invitrogen) following the manufacturer's 
protocol. Twenty four hours post transfection, MEFs were collected and the gene 
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silencing efficiency was examined by western blot analysis. Cell viability was 
measured using the PI exclusion method to determine if knock down of the two 
anti-apoptotic Bcl-2 proteins will cause spontaneous apoptosis. 
3.2.8. Quantitative real-time polymerase chain reaction (qPCR) 
Bcl-x wild-type, Noxa wild-type, and Noxa-KO MEFs were incubated with 0.4 mM 
H202 for 0,7 and 15 hours in 10 cm tissue culture plates. Total RNA was isolated 
using the RNeasy kit (Qiagen) following the manufacturer's instructions. RNA 
concentration was determined using a NanoDrop 8000 Spectrophotometer 
(Thermo) and the quality of total RNA determined with a 2100 Bioanalyzer 
(Agilent). One microgram of total RNA was used for reverse transcription 
polymerase chain reaction (rt-PCR) to generate cDNA using a High Capacity 
Reverse Transcript Kit (ABI; Forest City, CA) according to the manufacturer's 
instructions. The rt-PCR product was used in a TaqMan gene expression assay 
(ABI, Forest City, CA).The TaqMan 20x probes for the ten BH3-only Bcl-2 
proteins were used to detect expression levels of mRNA of the respective BH3-
only Bcl-2 proteins with tubulin serving as endogenous control. 
3.2.9. Statistical analysis 
All experiments were performed in triplicates and results expressed as mean ± 
standard deviation of at least three independent triplicate experiments. A two tail 
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student's t test was carried out and p:s; 0.05 was considered significant between 
samples and their respective controls. 
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3.3. Results 
3.3.1. Endogenous Bcl-Xl inhibits H202-induced apoptosis 
To determine whether endogenous BcI-2 proteins might be involved in the 
regulation of oxidative stress-induced apoptosis, we exposed MEFs described 
before in Figure 2.1 H202. Both wild-type and BcI-x-KO MEFs were incubated 
with 0.1-0.6 mM of H202 and cell viability was measured. Exposure to various 
concentrations of H202 resulted in more cell death in BcI-x-KO MEFs compared 
with wild-type MEFs, and cytotoxicity of H202 was dose-dependent (Figure 3.1A). 
Among all concentrations examined, 0.4 mM H202 exposure generated the 
biggest difference in viability between wild-type and Bcl-x-KO MEFs. It has been 
reported that moderate H202 concentrations cause apoptotic cell death and 
higher levels of H202 induce necrosis [93]. 
Following 0.1-0.6 mM H202 exposure, caspase 3/7 activity was measured to 
explore the range of H20 2 concentrations that were inducing apoptosis in wild-
type and Bcl-x-KO MEFs (Figure 3.1 B). For both cell lines, MEFs treated with 
0.4 mM H20 2 exhibited the highest levels of caspase 3/7 activity. Exposure to 
H202 concentrations higher than 0.4 mM induced more cell death, but lower 
caspase 3/7 activity, suggesting that 0.4 mM H202 provides the optimal level of 
apoptosis, and higher doses cause increasing MEF cell necrosis. Importantly, 
caspase 3/7 activity in BcI-x-KO MEFs treated with 0.4 mM H202 was higher than 
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that in wild-type MEFs, indicating that endogenous Bcl-xL is crucial for protection 
against H202-induced apoptosis. 
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Figure 3.1. Endogenous Bcl-XL inhibits H202-induced apoptosis (A) Wild-
type and Bcl-x-KO MEFs were treated with 0.1-0 .6 mM H 20 2 for the 
indicated times and cell viability was measured. Results are mean± 
standard deviation for three independent experiments performed in 
triplicate . **P<0 .01 ; Student's unpaired t test. (B) Fluorimetric assays were 
carried out to determine caspase 3/7 activity after 9 hour of treatment with 
0.1-0.6 mM H20 2. Values are normalized to those of the untreated cells, 
and results are mean±S.D. for three independent experiments performed 
in triplicate. *P<0 .05 ; **P<0 .01 ; Student's unpaired t test. 
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3.3.2. Endogenous Bcl-XL differentially antagonizes the activity of different 
pro-apoptotic BH3-only Bcl-2 proteins 
To determine the effects of pro-apoptotic BH3-only BcI-2 proteins on cell viability 
of wild-type and Bcl-x-KO MEFs, the cDNA of a panel of ten pro-apoptotic BH3-
only BcI-2 proteins including Bad, Bnip3, Nix, Bim, Bik, tBid, Bmf, Hrk, Puma and 
Noxa were first subcloned into the retroviral expressing vector pBABE having an 
enhanced green fluorescent protein (EGFP) as a marker expressed from an 
Internal Ribosomal Entry Site (IRES) [pBABEIIRES/EGFPl Each plasmid 
carrying the gene of interest was first transfected into T293 cells and retroviral 
supernatant collected. Wild-type and Bcl-x-KO MEFs were infected with retroviral 
supernatant expressing the individual BH3-only Bcl-2 proteins. As indicated by 
EGFP fluorescence intensity of cells, more than 95% of infected MEFs 
expressed the individual BH3-only BcI-2 proteins. Quantitative real time 
polymerase chain reaction (qPCR) was performed to ensure that each BH3-only 
BcI-2 protein was expressed at similar levels in both wild-type and Bcl-x-KO 
MEFs (Figure 3.2). 
Cell viability was measured at 0, 24 and 48 hours using the PI exclusion method. 
The BH3-only Bcl-2 proteins were categorized into three groups based on their 
effects on cell viability of MEFs. The first group includes Bad, Bnip3, Nix, and Bik. 
As shown in Figure 3.3, when wild-type and BcI-x-KO MEFs were infected with 
retroviral supernatant containing Bad, Bnip3, Nix, or Bik respectively, there was 
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no change in cell viability. Neither wild-type nor BcI-x-KO MEFs underwent 
apoptosis upon infection, indicating that these proteins do not directly interact 
with endogenous BcI-XL. The second group includes tBid, Puma, Bim, Bmf and 
Hrk. When tBid, Puma, Bim, Bmf or Hrk were expressed in wild-type and Bcl-x-
KO MEFs, there was no significant difference in cell viability. Both MEFs died at 
the same rate, showing that BcI-XL was not able to prevent cell death initiated by 
these BH3-only BcI-2 proteins (Figure 3.3). Finally, Noxa expression induced 
significant cell death in Bcl-x-KO MEFs but not in wild-type MEFs, indicating that 
the endogenous Bcl-XL is able to completely inhibit pro-apoptotic activities of 
Noxa (Figure 3.3). 
These data suggest that endogenous levels of Bcl-XL mediate cellular responses 
to pro-apoptotic BH3-only BcI-2 protein expression by differentially antagonizing 
their activities. When these ten pro-apoptotic BH3-only Bcl-2 proteins were 
treated with the Bcl-x-KO MEFs reexpressing different BcI-XL levels described in 
Figure 2.4A above, we found out that reexpression of Bcl-XL in the Bcl-x-KO 
MEFs also restored their ability to prevent apoptosis in a BcI-XL dose-dependent 
manner (Figure 3.4). 
91 
~ 60 Puma mRNA VI 15 Bad mRNA (I) Qj 
> > (I) 
~ 
<~40 < 10 .Wildtype Zt1l z~ 
0: E o:'g • Bcl-x-KO E ::120 E~5 (l)e:. (I) 
> > ;: ;: 
t1I 0 .! 0 Qj (I) 
0: Parental GFP Puma 0: Parental GFP Bad 
VI 
1000 VI 10 Noxa mRNA Qj tBid mRNA Qj > 
> 8 ~ 800 ~ < 
<~6 z~600 
Zt1I 0: .-
0:><4 E ~400 E~ (I) 
~~2 > 200 ;: 
;: t1I 
t1I 0 Qj 0 Qj 
Parental GFP Noxa 
0: Parental GFP tBid 0: 
~ 15 ~ 8 (I) 
BmfmRNA (I) Hrk mRNA > > ~ ~ 6 
< 10 < zc;:- z~4 0: E o:~ 
E~5 E:I: 
(I) (I)~2 
> > ;: 
~ t1I 0 t1I 0 Qj Qj 
0: Parental GFP Bmf 0: Parental GFP Hrk 
~ 20 VI 100 ' (I) Bim mRNA Qj Bnip3 mRNA > > 80 ~ 15 ~ 
< <~60 
~ 'E10 ZM 
Em ~ '~40 
(I)~5 co 
> ~~20 ;: ;: 
t1I 0 t1I 0 (I) 
Parental GFP Bim 
(I) 
Parental GFP Bnip3 0: 0: 
~ 400 ~ 15 (I) 
> BikmRNA (I) Nix mRNA 
~ > 300 ~ 
< < 10 Z~ 
0: ~200 Z~ o:~ 
E~ E~5 (I) 
100 > (I) ;: > 
.! ;: 0 t1I 0 (I) Qj 0: Parental GFP Bik 0: Parental GFP Nix 
92 
Figure 3.2. Expression levels of pro-apoptotic BH3-only Bcl-2 proteins in 
MEFs. Wild-type and BcI-x-KO MEFs were infected with retroviral 
supernatants expressing the different pro-apoptotic BH3-only Bcl-2 
proteins for 8 hours. Expression of the indicated BH3-only Bcl-2 proteins 
was determined by qPCR analysis. Note that the probes for human Bid 
were used to detect expression of tBid in MEFs and endogenous Bid 
expression levels in MEFs were almost undetectable. Data represents 
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Figure 3.3. Endogenous Bcl-XL most effectively inhibits Noxa-induced cell 
death. A panel of pro-apoptotic BH3-only BcI-2 proteins was expressed in 
wild-type and BcI-x-KO MEFs by retroviral infection, and cell viability was 
measured at the indicated time . The ten BH3-only BcI-2 proteins were 
categorized into three groups based on the effectiveness of endogenous 
BcI-XL to antagonize their pro-apoptotic activities. Data representative one 
BH3-only BcI-2 protein from each class are shown. Data represents mean 
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Figure 3.4. Reexpression of Bcl-XL in Bcl-x-KO MEFs restores their ability to 
prevent BH3-only Bcl-2 proteins-induced apoptosis. Reexpression of 
BcI-XL in Bcl-x-KO MEFs restored resistance to apoptosis in a BcI-xL dose-
dependent manner. The ten BH3-only BcI-2 proteins were infected with 
the different cell lines described in Figure 2.4A and cell viability was 
measured at the indicated time. Data show mean ± standard deviation of 
three independent experiments performed in triplicate. 
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3.3.3. Endogenous Bcl-XL prevents H20 2- and Noxa-induced apoptosis in a 
similar fashion 
Next, we looked at the effect of endogenous BcI-XL on apoptosis induced by the 
oxidative stress inducers H202, and the pro-apoptotic BH3-only BcI-2 proteins. 
Results demonstrate that endogenous Bcl-XL most efficiently inhibits apoptosis 
induced by H202 (Figure 2.3A and Figure 3.1A), and the pro-apoptotic BH3-only 
BcI-2 protein Noxa (Figure 3.3) in a similar manner. But, how the BcI-2 proteins 
are involved in oxidative stress-induced apoptosis is largely unclear. Since 
endogenous Bcl-XL was able to prevent Noxa- and H202-induced apoptosis in a 
similar fashion, I explored further the mechanism by which H202 induces 
apoptosis. Previous studies have shown that Noxa interacts with the anti-
apoptotic Bcl-2 protein McI-1 and sequesters it for degradation. I therefore 
proposed that the oxidative stress inducer H202 activates Noxa expression, 
which in turn leads to Mcl-1 degradation and subsequent apoptosis. Therefore, I 
investigated the sequence of events involving the BcI-2 proteins BcI-XL, Noxa and 
McI-1 during H202-induced apoptosis. 
3.3.4. Noxa mediates H202-induced apoptosis 
To investigate the role of the pro-apoptotic BH3-only BcI-2 proteins on apoptosis 
induced by H202, I carried out microarray analysis to determine the global 
changes in mRNA expression levels of the different BcI-2 proteins in wild type 
MEFs. Upon H202 exposure, the most notable increase in gene expression within 
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the 8H3-only 8cl-2 protein family was Noxa, while the other 8H3-only 8c1-2 
proteins showed smaller changes in gene expression (Figure 3.5A). Noxa gene 
expression level was dramatically ~ncreased at the 7 hour time point, and the fold 
increase was smaller at the 15 hour time point, suggesting that the increase 
might be transient. The upregulation of Noxa mRNA was also validated using 
qPCR, indicating that Noxa expression is increased during oxidative stress 
inducer, H202-induced apoptosis (Figure 3.58). 
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Figure 3.5. H20 2 induces Noxa expression. (A) Noxa mRNA displayed the 
greatest increase upon H202 treatment among BH3-only Bcl-2 proteins. 
Microarray analysis was used to determine changes of mRNA levels in 
wild-type MEFs after exposure to 0.4 mM H202 for 7 hours and 15 hours. 
The fold change in mRNA levels of different BH3-only Bcl-2 proteins was 
calculated using the values at 0 hour time point as a control. (8) 
Quantitative real-time polymerase chain reaction (qPCR) showed 
expression levels of Noxa and Puma mRNA after treating wild-type MEFs 
with 0.4 mM H20 2. Data represent the mean ± standard deviation of three 
independent experiments performed in triplicates. Asterisks indicate P < 
0.05 (*), P < 0.01 (**), or P < 0.001 (***), Student's unpaired t test. 
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To further explore the importance of Noxa in H20 2-induced apoptosis, I 
investigated the effects of decreased Noxa expression on cell sensitivity to H202. 
MEFs deficient in Noxa expression (Noxa-KO) and their wild-type counterparts 
were provided by Professor Andreas Strasser (Walter and Eliza Hall Institute of 
Medical Research, Parkville, VIC Australia). Due to a lack of effective anti-murine 
Noxa antibodies, I failed to detect Noxa protein expression in any MEFs 
examined. However, the results from qPCR experiments confirmed that Noxa 
mRNA was expressed in wild-type but not in Noxa-KO MEF cells (Figure 3.6A). 
When treated with 0.1-0.6 mM H20 2, MEF cell death increased in a H202 dose-
dependent manner and wild-type MEFs were more sensitive to H20 2 than Noxa-
KO MEFs, providing evidence that H202-induced apoptosis is primarily mediated 
by Noxa in MEFs (Figure 3.68). Furthermore, the biggest difference in cell 
viability between wild-type and Noxa-KO MEFs was observed for MEFs treated 
with 0.4 mM H202. Importantly, 0.4 mM H202 exposure induced highest caspase 















~~ 300 <':6 t:E E lO "'3 
.. 












:c 5 40 
20 
0 








IV 40 :> 
20 
0 





0.1 0 .2 0.3 0.4 0 .5 0 .6 
[H20 21/mM 
Figure 3.6. H20 2-induced apoptosis is mediated by Noxa. (A) Noxa mRNA 
levels in wild-type and Noxa-KO MEFs were determined by qPCR. (8) 
Noxa wild-type and Noxa-KO MEFs were treated with 0.1-0.6 mM H202 
and cell viability measured at the indicated time. Data represent mean ± 
standard deviation of three separate triplicate experiments. (C) Caspase 
3/7 activity was determined using the fluorometric assay after treatment of 
wild-type and Noxa-KO MEFs with 0.1-0.6 mM H202 for 9 hours. Values 
were normalized to those of untreated control cells . Asterisks indicate P < 
0.05 (*), P < 0.01 (**), or P < 0.001 (***), Student's unpaired t test. 
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3.3.5. Reduction of Mcl-1 expression in response to H202 treatment is 
dependent on Noxa but not on Bcl-xL. 
As the pro-apoptotic BH3-only BcI-2 protein Noxa has been shown to interact 
with the anti-apoptotic Bcl-2 protein McI-1 and cause Mcl-1 degradation [129], we 
explored whether H202-induced Noxa expression led to reduced Mcl-1 
expression levels. Noxa wild-type and Noxa-KO MEFs were treated with H202, 
and McI-1 expression levels were determined by western blot analysis (Figure 
3.7A and 3.7B). Upon H202 exposure, McI-1 protein was decreased in Noxa-
expressing wild-type cells in a time-dependent manner. In contrast, Mcl-1 
expression was not affected by H202 in Noxa-KO MEFs (Figure 3.7A and 3.7B). 
The lack of Mcl-1 downregulation in Noxa-KO MEFs provides more evidence that 
H202-induced Mcl-1 expression reduction is mediated by Noxa. Since pro-
apoptotic activities of Noxa depend on endogenous BcI-XL expression (Figure 
3.3), we examined the influence of endogenous BcI-XL in McI-1 expression 
decrease caused by H202 exposure. When treated with H202, McI-1 expression 
levels decreased to comparable degrees in both wild-type and Bcl-x-KO MEFs, 
indicating that Bcl-XL does not influence the McI-1 down-regulation induced by 
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Figure 3.7. Mcl-1 expression reduction in response to H202 depends on 
Noxa but not Bcl-XL' (A) Wild-type and Noxa-KO MEFs were exposed to 
0.4 mM H20 2 for the indicated time and cell Iysates were collected. 
Western blot analysis determined the Mcl-1 expression levels. Images 
represent one of three independent experiments. (B) Normalized 
summary of McI-1 levels in the indicated cell lines shown in (A). The 
values of Mcl-1 levels were normalized to those in the untreated cells. 
Data represent the mean ± standard deviation of three independent 
experiments. (C) Wild-type and 8c1-x-KO MEFs were treated with 0.4 mM 
H20 2 and cell Iysates were obtained at the indicated time points. McI-1 
expression levels were assessed by western blot analysis. The results of 
one of three independent experiments are shown. (0) The levels of Mcl-1 
shown in (C) were normalized as described in (8). Data represent the 
mean ± standard deviation of three independent experiments. Asterisks 
indicate P < 0.05 (*) or P < 0.01 (**), and (ns) no significance, Student's 
unpaired t test. 
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3.3.6. Mcl-1 overexpression inhibits H20'2-induced apoptosis 
To further explore the importance of Mcl-1 reduction in H202-induced apoptosis, 
McI-1 was overexpressed in wild-type and 8cl-x-KO MEFs by retroviral infection 
and western blot analysis used to determine McI-1 expression levels in MEFs 
(Figure 3.8A). MEFs with different McI-1 expression levels were exposed to 0.4 
mM H202 and cell viability was determined. Overexpressed McI-1 prevented 
H202-induced apoptosis in both wild-type and 8c1-x-KO MEFs (Figure 3.88). In 
addition, caspase 3/7 activity measurement confirmed that McI-1 overexpression 
inhibited apoptosis induced by H202 (Figure 3.8C), in support of the notion that 
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Figure 3.B. Mcl-1 overexpression inhibits H20 2-induced apoptosis. (A) Mcl-1 
was stably overexpressed in both wild-type and Bcl-x-KO MEFs. Western 
blot analysis determined the expression levels of Mcl-1 in the indicated 
cell lines. (8) Wild-type and Bcl-x-KO MEFs with or without McI-1 
overexpression were treated with 0.4 mM H20 2 for the indicated time 
period, and cell viability measured. Data represent the mean ± standard 
deviation of three independent experiments performed in triplicate. 
Asterisks indicate P < 0.01 (**) or P < 0.001 (***), Student's unpaired t 
test. (C) Caspase 3/7 activity was determined using the fluorometric assay 
for cell lines described in (A) following 9 hour treatment with 0.4 mM H202. 
Values were normalized to those of the untreated cells. Data are shown as 
the mean ± standard deviation of three independent experiments 
performed in triplicate. Asterisks indicate P < 0.05 (*) or P < 0.01 (**), 
Student's unpaired t test. 
107 
3.3.7. Reduction of both Bcl-XL and Mcl-1 protein expression in MEFs 
induces spontaneous apoptosis (synthetic lethality). 
We have shown that lacking endogenous Bcl-XL expression sensitized cells to 
both H202 treatment (Figure 2.3A) and Noxa expression (Figure 3.3), and Noxa-
dependent decrease in McI-1 expression is important for cell death induced by 
H202 (Figure 3.8B). Therefore, we reasoned that Bcl-XL and Mcl-1 were two anti-
apoptotic BcI-2 proteins critical to prevent apoptosis in general and H20 2-induced 
apoptosis in particular. Thus, we investigated the influence of reducing BcI-XL and 
Mcl-1 expression simultaneously on cell survival. To this purpose, we first 
reduced McI-1 expression in Bcl-x-KO MEFs. Upon Mcl-1 siRNA transient 
expression, Mcl-1 expression decreased in both wild-type and Bcl-x-KO MEFs, 
whereas expression of other anti-apoptotic Bcl-2 proteins, including Bcl-XL, BcI-2 
and BcI-w, appeared unchanged (Figure 3.9A). The reduction of Mcl-1 
expression in wild-type MEFs was more dramatic than that in Bcl-x-KO MEFs 
(Figure 3.9B). While knocking down Mcl-1 expression failed to affect 
spontaneous wild-type cell death, reduced McI-1 expression in Bcl-x-KO MEFs 
caused significantly more cell death (Figure 3.9C). 
To further validate the role of BcI-XL and Mcl-1 in maintaining cell survival, a 
reciprocal experiment was performed to knock down Bcl-XL expression in wild-
type and McI-1-KO MEFs (Figure 3.90). Twenty four hours following transfection, 
Bcl-XL expression was reduced to comparable levels in wild-type and McI-1-KO 
MEFs by Bcl-XL siRNA (Figure 3.9E). Much higher levels of spontaneous 
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apoptosis were observed in McI-1-KO MEFs with reduced Bcl-xL expression, 
whereas decreased Bcl-xL expression did not affect cell survival in wild-type 
MEFs (Figure 3.9F). Overall, these results indicate that BcI-xL and McI-1 are 
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Figure 3.9. Reduction in Bcl-xl and Mcl-1 expression simultaneously 
induces spontaneous apoptosis. (A) Expression of Mcl-1 and several 
anti-apoptotic BcI-2 proteins in the indicated wild-type and Bcl-x-KO MEFs 
were determined by western blot 24 hours post siRNA transfection. (B) 
The summary of normalized McI-1 levels shown in (A). McI-1 levels were 
normalized to those in the untreated cells. Data represent the mean ± 
standard deviation of three independent experiments. (C) Reduction of 
Mcl-1 expression in Bcl-x-KO MEFs induced spontaneous cell death 24 
hours following siRNA transfection. Mean ± standard deviation for three 
independent experiments are shown. (0) Bcl-XL expression was reduced 
in both wild-type and Mcl-1-KO MEFs by siRNA 24 hours after 
transfection. (E) Normalized summary of BcI-XL levels in the indicated cell 
lines shown in (D). Data represent the mean ± standard deviation of three 
different experiments. (F) Decreasing BcI-XL expression caused cell death 
in McI-1-KO MEFs 24 hours following transfection. Mean ± standard 
deviation for three independent experiments are shown. Asterisks indicate 
P < 0.05 (*) or P < 0.001 (***), Student's unpaired t test. 
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3.4. Discussion 
Oxidative stress-induced apoptosis is a well-described phenomenon, but the 
precise mechanisms through which oxidative stress is coupled with ultimate cell 
death are not completely clear. In this specific aim, I investigated the roles of 
both anti- apoptotic and pro-apoptotic Bcl-2 proteins in regulating cell death 
caused by oxidative stress in the form of H202. Upon H202 exposure, 
endogenous anti-apoptotic BcI-XL seemed to be essential for MEF cell survival. 
Systematic examination of the involvement of pro-apoptotic BH3-only BcI-2 
proteins in H202-induced apoptosis revealed that Noxa was the major mediator of 
H202 cytotoxicity in MEFs. Furthermore, H20 2-induced Noxa expression led to 
reduction in Mcl-1 expression, which in turn co-operated with decreased BcI-XL 
levels to trigger apoptotic signaling. Overall, our studies provide molecular 
evidence that Bcl-2 family of proteins function co-operatively to modulate cellular 
responses to oxidative stress. 
Cellular responses to any apoptotic trigger, including oxidative stress, are 
modulated by complex BcI-2 networks [46, 75]. In response to apoptotic stimuli, 
activity of BH3-only BcI-2 proteins is up-regulated either by an increase in 
transcription or by post-translational modification, such as caspase-8-mediated 
proteolysis of Bid [130], phosphorylation of Bim [131], and dephosphorylation of 
Bad [132]. This present study focuses on investigating whether transcriptional 
induction of a particular BH3-only BcI-2 protein mediates oxidative stress-
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triggered cell death. The possible role of post-translational modification of BH3-
only Bcl-2 proteins in oxidative stress-induced apoptosis is not addressed here. It 
is conceivable that post-translational modification of one or more BH3-only Bcl-2 
proteins might also be involved in apoptosis induced by oxidative stress. Modest 
caspase 3/7 activity observed in H20 2-treated Noxa-KO MEFs suggests that 
BH3-only Bcl-2 proteins other than Noxa are also involved in oxidative stress-
induced apoptosis, albeit a minor role in MEFs. 
Several BH3-only BcI-2 proteins have been proposed to be involved in cell death 
caused by H202. Murine retinal explants deficient in Bim expression are more 
resistant to H20 2 treatment compared with retinal explants expressing Bim [133]. 
In fibroblasts, Bik expression is crucial for H202-triggered cell death [127]. In 
agreement with our observations, Noxa is largely responsible for the cytotoxicity 
of H202 in T leukemia Jurkat cells [128]. Thus, the involvement of a particular 
BH3-only Bcl-2 protein in H202-induced apoptosis appears to depend on cell 
type, which could be attributed to cell type-specific transcriptional responses to 
cell death stimuli. While the proline- and acid-rich (PAR) subfamily of basic 
leucine-zipper (bZIP) transcriptional factor family is responsible for Bik 
expression increase in H202-exposed MEFs [127], the activating transcription 
factor 4 (ATF4) has been implicated in the induction of Noxa expression in Jurkat 
cells upon H20 2 exposure [128]. It is still unclear how oxidative stress-induced 
apoptosis signalling is transduced into the nucleus to induce the transcription of 
BH3-only Bcl-2 proteins. The cytotoxicity of oxidative stress is believed to be 
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mediated by reactive oxygen species (ROS) and reactive iron [134, 135]. 
Membrane rupture of Iysosomes, the organelle with most abundant labile iron, 
results in translocation of redox-active iron to the nucleus, which might be 
responsible for generating oxidative damage to DNA and subsequent 
transcriptional responses [136]. In support of this model, the Iysosomotropic iron 
chelator deferoxamine (DFO) prevents production of more reactive species of 
ROS, lysosomal rupture and subsequent cell death [134, 135, 137]. 
It has been proposed that BH3-only BcI-2 proteins function to inhibit activities of 
anti-apoptotic Bcl-2 proteins and/or activate multidomain effector BcI-2 proteins 
Bak and Bax [74]. The differential interactions between BH3-only Bcl-2 proteins 
and anti-apoptotic BcI-2 proteins enable the complex BcI-2 network to modulate 
apoptotic signalling. Through BH3 peptide and protein binding assays, the 
interactions between BH3-only Bcl-2 proteins and anti-apoptotic Bcl-2 proteins 
have been quantified [138, 139]. While some BH3-only BcI-2 proteins, such as 
Bim and Puma, engage all anti-apoptotic Bcl-2 proteins, Noxa is believed to 
interact with McI-1 with highest affinity in vitro. Although Bim, Puma, Bmf, and 
Hrk have been shown to bind to Bcl-XL, endogenous BcI-XL failed to provide any 
protection against the expression of each of these BH3-only BcI-2 proteins 
(Figure 3.3). One possible scenario is that endogenous BcI-XL was overwhelmed 
by expression of these BH3-only BcI-2 proteins. However, our current knowledge 
of the interactions between BH3-only BcI-2 proteins and Bcl-XL are largely based 
on studies of BH3 domain peptides and recombinant proteins. The results 
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obtained from these in vitro studies might not truthfully reflect the physiological 
interactions between endogenous Bcl-XL and BH3-only Bcl-2 proteins inside 
cells. Remarkably, Noxa was the only BH3-only BcI-2 protein whose pro-
apoptotic activities were completely abolished by endogenous Bcl-XL, even 
though cytotoxicity of Noxa on Bcl-x-KO MEFs was comparable to those of Bim, 
Puma, Bmf, tBid and Hrk (Figure 3.3). 
The simple explanation for this observation is that endogenous BcI-XL directly 
binds to Noxa and completely sequesters all ectopically expressed Noxa. 
Indeed, a recent study indicates that BcI-XL may directly interact with Noxa in 
HeLa cells [140]. However, the observed interaction between BcI-XL and Noxa is 
weak, as only overexpressed BcI-XL but not endogenous Bcl-XL has been found 
to bind Noxa following DNA damage. This seems not to be the case in our 
studies. If endogenous BcI-XL directly bound and sequestered Noxa in H202-
treated MEFs, reduction of McI-1 expression would be more dramatic in BcI-x-KO 
MEFs, since more unbound Noxa proteins would be available to engage Mcl-1 in 
the absence of BcI-XL. In fact, similar reduction of Mcl-1 expression was observed 
in wild-type and BcI-x-KO MEFs (Figure 3.7), suggesting that Noxa does not 
directly engage endogenous Bcl-XL in MEFs. Instead, our studies provide 
evidence that H20 2-induced Noxa expression causes McI-1 down-regulation, 
which is involved in H202 cytotoxicity. 
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Our data demonstrate that BcI-XL and Mcl-1 are two major anti-apoptotic Bcl-2 
proteins protecting cells against basal pro-apoptotic activities in healthy cells. 
Apoptosis was initiated when McI-1 expression was reduced in BcI-x-KO MEFs 
or Bcl-XL expression was decreased in the MEFs lacking Mcl-1 expression 
(Figure 3.9), which is consistent with the previous studies in HeLa cells [140]. 
The nature of basal pro-apoptotic activities triggering apoptosis in the absence of 
BcI-XL and Mcl-1 is not completely understood. One intriguing possibility is that 
multidomain Bak is kept inactive by Bcl-XL and Mcl-1 in healthy cells [129]. But in 
the presence of apoptotic stimuli, BH3-only BcI-2 proteins are activated to 
displace both BcI-XL and Mcl-1 from Bak, such as Bad for BcI-XL and Noxa for 
Mcl-1. Bak is then freed and activated, and activated Bak subsequently forms 
permeation channels on mitochondria and promotes OMM permeabilization. 
However, other studies indicate that Bak is not kept in check by BcI-XL and or 
McI-1 [141]. Instead, the mitochondrial protein voltage-dependent anion channel 2 
(VDAC2) is found to sequester Bak and keep it inactive. Whether Bak activation 
is responsible for oxidative stress-induced cell death or not warrants further 
investigation. In summary, our studies define the important roles of several 




Figure 3.10. Bcl-2 proteins coordinately regulate H202-induced apoptosis. 
Oxidative stress (H202) induces Noxa expression, leading to reduction of 
Mcl-1 expression. In the absence of BcI-xL, cells undergo apoptosis. 
Endogenous Bcl-xL protects against cell death induced by H202. 
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CHAPTER IV 
THE IMPORTANT ROLE OF LYSOSOMAL MEMBRANE PERMEABILIZATION 
DURING OXIDATIVE STRESS-INDUCED APOPTOSIS 
4.1. Introduction 
Apoptosis is regulated by the BcI-2 family of proteins, which can either be pro-
apoptotic or anti-apoptotic [3, 44, 45]. Pro-apoptotic Bcl-2 proteins promote or 
induce apoptosis by increasing OMMP, whereas anti-apoptotic BcI-2 proteins 
inhibit OMMP and prevent or delay apoptosis [46, 74, 75]. Although mitochondria 
playa central role in apoptosis regulation, other organelles including the ER, the 
golgi aparatus, and the Iysosomes are also involved in apoptosis regulation [53, 
142, 143]. Lysosomes are major intracellular organelles responsible for 
degrading and recycling of cellular components. Lysosomes contain at least 50 
hydrolytic enzymes including nucleases, proteases, phospholipases, lipases, 
phosphatases, sulfatases and glycosidases which, upon release, can degrade 
macromolecules in the cytosol [144]. 
The best characterized lysosomal enzymes belong to the cathepsin protease 
family. A wide variety of stressors including osmotic stress, growth factor 
deprivation, death receptor activation, proteasome inhibitors and oxidative stress 
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inducers have been shown to target Iysosomes and cause lysosomal membrane 
permeabilization (LMP) through which lysosomal hydrolytic enzymes are 
released into the cytosol [145]. The degree of lysosomal damage determines the 
cell's fate. Massive lysosomal damage causes an excessive release of lysosomal 
contents into the cytosol resulting in indiscriminate degradation of cellular 
contents and cytoplasmic acidification, which in turn promotes cell death by 
necrosis. On the other hand, selective or partial lysosomal damage induces cell 
death by apoptosis [146-148]. For instance, in TNFa-treated cells, cathepsin B, 0 
and L released into the cytosol trigger apoptosis by converting the inactive full 
length pro-apoptotic BH3-only BcI-2 protein Bid into its truncated (activated) form 
(tBid) promoting subsequent OMMP and caspase activation [145, 149]. 
Oxidative stress inducers, including H202, are capable of inducing cell death by 
both necrosis and apoptosis; mild oxidative stress causes apoptosis whereas 
severe oxidative stress triggers necrosis [93]. The extent of oxidative stress 
determines the degree of lysosomal membrane damage. In Iysosomes, H202 
interacts with iron to generate highly reactive hydroxyl radicals that initiate lipid 
peroxidation of lysosomal membranes and subsequent LMP. In support of this 
model, the iron chelating agent desferrioxamine (DFO) has been shown to 
abolish oxidative stress-triggered LMP and apoptosis [150]. However, the 
involvement of LMP in oxidative stress-induced apoptosis signaling and how 
LMP is modulated by the Bcl-2 protein network are unclear. Here, I investigated 
the temporal relation between LMP and OMMP during oxidative stress-induced 
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apoptosis. In mouse embryonic fibroblasts (MEFs), H20 2 was able to induce LMP 
prior to OMMP during apoptosis. Outer mitochondrial membrane 
permeabilization and subsequent apoptosis signaling, but not LMP, depended on 
Noxa expression. The iron chelating agent DFO prevented H202-induced OMMP 
and apoptosis by inhibiting LMP and subsequent increase in Noxa expression. 
Therefore, LMP-induced Noxa expression is critical for OMMP and subsequent 
activation of the apoptosis cascade during oxidative stress. 
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4.2. Materials and Methods 
4.2.1. Reagents 
DFO, etoposide, doxorubicin, actinomycin D, hydrogen peroxide (H202), acridine 
orange (AO), and ferric ammonium citrate were purchased from Sigma (St. 
Louis, MO). Staurosporine, cisplatin, and carboplatin were from Enzo 
(Farmingdale, NY). Propidium iodide (PI), MitoTracker Green, MitoTracker Red, 
and puromycin were from Invitrogen (Carlsbad, CA). Unless otherwise stated, all 
reagents were dissolved in DMSO. DMEM, penicillinlstreptomycin (PIS), trypsin, 
and L-glutamine were obtained from Mediatech (Manassas, VA), and FBS was 
purchased from Gemini (Broderick, CA). The jetPRIME® transfection reagent 
was from Polyplus-transfection (NYC, NY). The SensoLyte® Homogeneous 
Rh110 caspase 3/7 assay kit was from AnaSpec (San Jose, CA). Antibodies 
(Abs) used for western blot were anti-J3-actin mAb (Sigma), anti-Noxa pAb 
(Imgenex; San Diego, CA), anti-cytochrome c (BD Pharmingen), peroxidase-
conjugated goat anti-rabbit IgG (Thermo; Waltham, MA) and peroxidase-
conjugated goat anti-mouse IgG (Thermo). 
4.2.2. Cell lines and cell culture 
MEFs deficient in the expression of the anti-apoptotic Bcl-2 protein BcI-XL (BcI-x-
KO) and their wild-type counterparts were used. Noxa-KO MEFs and their wild-
type counterparts were provided by Professor Andreas Strasser (Walter and 
Eliza Hall Institute of Medical Research, Parkville, VIC Australia). All MEFs were 
121 
grown and maintained in DMEM supplemented with 10% FBS and 100 unitslml 
of penicillin and 100 I-Ig/ml of streptomycin. 
The bulk populations of the human colon cancer cell lines (HCT116) stably 
expressing Noxa shRNA or the control luciferase shRNA were provided by Dr. 
Onno Kranenberg (University Medical Center Utrecht; Utrecht, Netherlands). The 
limited dilution method was used to obtain single clones, and Noxa expression 
was examined by western blot. The HCT116 cells were grown and maintained in 
DMEM supplemented with 5% FBS, 100 unitslml of penicillin, 100 I-Ig/ml of 
streptomycin, 2 mM L-glutamine and 0.5 I-Ig/ml of puromycin. Cells were all 
cultured in a 5% C02 humidified incubator at 37 cC. 
4.2.3. Plasmid construction and retrovirus production 
Murine Noxa cDNA was subcloned into the retroviral expression vector pBABE-
IRES-EGFP with the marker protein enhanced green fluorescence protein 
(EFGP) expressed from an internal ribosomal entry site (IRES) as described 
previously [151]. For retrovirus production, the human embryonic kidney (HEK)-
293T cells were transfected with the plasmid pBABE-mNoxa-IRES-EGFP or the 
empty vector and the helper plasm ids pUVMC and pMDG2.0 using the 
jetPRIME® transfection reagent. Retroviral supernatant was collected 48-72 
hours after transfection and supplemented with 10 Ilglml polybrene to increase 
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infection efficiency. Retrovirus expressing murine Noxa or GFP-only was used to 
infect MEFs and cell viability was determined at the indicated time. 
4.2.4. Cell viability 
The propidium iodide (PI) exclusion method was used to determine cell viability. 
Cells were plated in 48-well tissue culture plates at the density of 1 x 104 cells 
per well 24 hours before exposure to death stimuli. Cells were pre-incubated with 
or without 1 mM of the high-affinity iron chelator DFO for two hours. Cells were 
then washed twice with fresh medium before exposure to the respective death 
stimuli. At the indicated time, cells were collected in the presence of 1.0 /lg/ml of 
PI and the percentage of live cells was measured using a flow cytometry analysis 
(FACScalibur, Beckon Dickinson; San Jose, CA) as described previously [103]. 
Cell viability of treated cells was calculated as the percentage of the viability of 
the untreated cells. 
4.2.5. Caspase 3/7 activity 
Approximately 5 x 103 MEFs were cultured in white-walled 96-well tissue culture 
plates for 24 hours. MEFs were pre-incubated with or without 1 mM DFO for two 
hours, washed twice with fresh medium before an exposure to the respective 
death stimuli. MEFs were treated with H202 or actinomycin D for 7 hours, 
exposed with etoposide, staurosporine, or doxorubicin for 12 hours, or infected 
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with the retroviral supernatant expressing Noxa for 14 hours. Caspase 3/7 
activity was determined using the Sensolyte® Homogeneous R 110 Caspase 3/7 
Assay Kit (AnaSpec) according to the manufacturer's protocol. Caspase 3/7 
activity of treated or infected cells was normalized to that of untreated controls. 
The results were presented as relative fluorescence units per minute (RFUs/min). 
4.2.6. Western blot analysis 
Equal amounts of proteins (30 j.Jg) were separated on a 4-12% Bis-Tris gel (Bio-
Rad; Hercules, CA) and transferred onto PVDF membrane (Millipore; Billerica, 
MA). The membrane was incubated with the appropriate primary or secondary 
antibodies either overnight at 4°C or at room temperature for 3 hours in 1 X 
phosphate-buffered saline (PBS) containing 5% (w/v) nonfat dry milk (Bio-Rad) 
and 0.2% (v/v) Tween 20. Protein levels were detected using the enhanced 
chemiluminescent detection system (Pierce, Rockford, IL). 
4.2.7. Microarray analysis 
MEFs were pre-incubated with or without 1 mM DFO for 2 hours, washed twice 
with fresh medium before a treatment with either 0.4 mM H202 for 6 hours or 0.3 
mM iron ammonium citrate for 24 hours. Total RNA was acquired using the 
RNeasy kit (Qiagen; Germantown, MD) according to the manufacturer's 
instructions. RNA concentrations were determined with a NanoDrop 8000 
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Spectrophotometer (Thermo), and the quality of total RNA was evaluated by a 
2100 Bioanalyzer (Agilent; Santa Clara, CA). Global mRNA level alterations were 
determined using the GeneChip Mouse Gene 1.0 ST Array for H20 2 experiments 
or GeneChip Mouse Genome 430 2.0 Array for ferric ammonium citrate 
experiments (Affymetrix; Santa Clara, CA). 
4.2.8. Quantitative real time Polymerase Chain Reaction (qPCR) 
Total RNA was extracted using the RNeasy kit (Qiagen) and its concentration 
was measured using a NanoDrop 8000 Spectrophotometer (Thermo). Equal 
amounts (1 ~g) of total RNA were reverse transcribed. The TaqMan 20x probes 
for murine and human Noxa (Applied Biosystems; Carlsbad, California) were 
used to determine Noxa mRNA expression levels in MEFs and HCT116 cells 
respectively. In MEFs tubulin was used as the endogenous control, whereas 
actin served as the endogenous control in human HCT116 cells. 
4.2.9. Lysosomal membrane stability 
The Iysosomotropic base acridine orange (AO) was used to determine lysosomal 
membrane stability during H202-induced apoptosis. Two complementary 
experiments were carried out to measure lysosomal membrane stability by 
assessing changes in either green fluorescence (AO relocation method) or red 
fluorescence (AO uptake method) upon an exposure to H202 [143]. In both 
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cases, wild-type and Noxa-KO MEFs were plated in 48-well tissue culture plates 
at a density of 2 x 104 per well and cultured for 24 hours. For AO relocation 
experiments, the increase in green fluorescence was evaluated to detect early or 
minor changes in lysosomal membrane stability. MEFs were pre-incubated with 
or without 1 mM DFO for 2 hours, washed twice with fresh medium, before an 
exposure to 5 llg/ml of AO for 30 minutes. MEFs were then treated with 0.4 mM 
H202 for the indicated time, and changes in green fluorescence were determined 
by flow cytometry (FACScalibur, FL 1 channel). AO uptake experiments 
measured changes in red fluorescence to detect severe or late lysosomal 
membrane damage. Here, MEFs were pre-treated with or without 1 mM DFO for 
2 hours, rinsed twice with fresh medium, followed by an exposure to 0.4 mM 
H202 for one hour. MEFs were then returned to normal culture conditions by 
washing and replacing with fresh medium. At the indicated time, cells were 
treated with 5 llg/ml of AO for 15 minutes, and flow cytometry analysis was used 
to measure changes in red fluorescence (FACScalibur, FL3 channel). 
4.2.10. Mitochondrial membrane potential 
The mitochondrion-selective probes MitoTracker Green and MitoTracker Red 
were used to determine changes in mitochondrial membrane potential. Wild-type 
and Noxa-KO MEFs were plated in 48-well tissue culture plates at a density of 2 
x 104 and cultured for 24 hours. Following a treatment with 0.4 mM H202 for the 
indicated time, MEFs were then incubated with 200 nM MitoTracker Green or 
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200 nM MitoTracker Red for 1 hour. Green and red fluorescence of collected 
MEFs were analyzed using a flow cytometer (FACScalibur). Mitochondrial 
membrane potential was shown as the ratio of fluorescence intensity of 
mitochondrial potential-sensitive MitoTracker Red (FL3 channel) and 
mitochondrial potential-independent MitoTracker Green (FL 1 channel). 
4.2.11. Statistical analysis 
All experiments were performed in triplicate at least three times. Results are 
presented as mean ± standard deviation. Statistical analysis was performed 




4.3.1. Oxidative stress-induced LMP is independent of Noxa expression. 
In the Iysosomes, the oxidative stress inducer H202 interacts with iron in a redox 
reaction to produce highly reactive hydroxyl radicals, which in turn cause LMP 
and subsequent apoptosis [152-154]. Our previous studies have shown that the 
elevated expression of the pro-apoptotic BH3-only Bcl-2 protein Noxa mediates 
apoptosis triggered by H202 [151]. To explore further the important role of Noxa 
expression in H202-induced apoptosis, we first examined whether Noxa 
expression influenced H202-induced LMP using MEFs deficient in Noxa 
expression (Noxa-KO) and their wild-type counterparts. The Iysosomotropic base 
acridine orange (AO) is a metachromatic fluorochrome exhibiting red 
fluorescence when it is highly concentrated in intact Iysosomes, but emitting 
green fluorescence when its concentration is low as observed in Iysosomes with 
disrupted membrane integrity [124]. Two complementary approaches (AO 
relocation and AO uptake) were used to examine lysosomal membrane stability 
following H20 2 exposure. In AO relocation experiments, wild-type and Noxa-KO 
MEFs were first incubated with 5 Ilg/ml of AO before exposure to 0.4 mM H20 2. 
Thirty minutes post H202 treatment, there was a significant increase in green 
fluorescence levels in wild-type and Noxa-KO MEFs, indicating minor damage to 
lysosomal membrane integrity (Figure 4.1A). Importantly, the green fluorescence 
intensity increase was similar in both cell lines, providing evidence that Noxa 
expression did not influence H202-induced LMP despite its critical role in 
mediating apoptotic signaling pathways. Furthermore, pre-incubating cells with 1 
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mM of the highly potent iron chelator desferrioxamine (OFO) prevented LMP 
independent of Noxa expression (Figure 4.1A). 
To assess further the effects of Noxa expression on late lysosomal membrane 
rupture, we carried out AO uptake experiments to estimate the percentage of 
"pale" cells (cells with damaged Iysosomes). Following one hour-treatment with 
H202, MEFs were cultured in normal growth medium, and the intensity of red 
fluorescence emitted from AO inside cells was determined. Twenty four hours 
later, the fraction of cells displaying "pale" cell phenotype markedly increased in 
both wild-type and Noxa-KO MEFs, indicating late lysosomal membrane rupture 
(Figure 4.1 B). Furthermore, the increase in late lysosomal membrane rupture 
was abolished by pre-incubation with OFO. Consistent with the results of AO 
relocation experiments (Figure 4.1A), H20 2 was able to induce comparable late 
lysosomal membrane rupture in wild-type and Noxa-KO MEFs (Figure 4.1C). 
Overall, these results indicate that H202 induces LMP independent of Noxa 
expression, suggesting that Noxa mediates H202-triggered apoptosis at a phase 
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Figure 4.1. H202 induced Noxa-independent LMP. (A) Wild-type and Noxa-KO 
MEFs were pre-incubated with or without 1 mM DFO for 2 hours, followed 
by an exposure to 5 Ilg/ml acridine orange (AO) for 15 minutes. MEFs 
were then treated with 0.4 mM H202 for the indicated time. Green 
fluorescence emitted from AO inside cells was determined using flow 
cytometry analysis. Data represent mean ± standard deviation of three 
independent experiments performed in triplicates. (8) Following pre-
incubation with or without 1 mM DFO for 2 hours, wild-type and Noxa-KO 
MEFs were exposed to 0.4 mM H202 for 1 hour. MEFs were then cultured 
in normal growth medium for 24 hours. MEFs deficient in intact Iysosomes 
('pale' cells) were analyzed by flow cytometry. Data represent one of three 
independent experiments. (C) The summary of the experimental results 
shown in (8). The data are shown as mean ± standard deviation of three 
independent experiments performed in triplicates. 
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4.3.2. Noxa-dependent outer mitochondrial membrane permeabilization 
(OMMP) occurs downstream of LMP during H202-induced apoptosis. 
The OMMP and subsequent release of apoptogenic proteins such as cytochrome 
c from mitochondria to the cytosol are the molecular hallmarks of apoptosis [39]. 
To determine the temporal relation between MOMP and LMP during H202-
induced apoptosis, we first examined the amounts of cytochrome c released into 
the cytosol as an indicator of OMMP. To this purpose, both wild-type and Noxa-
KO MEFs were treated with H202, and the presence of cytochrome c in cytosolic 
fractions was determined by western blot (Figure 4.2A). The levels of cytochrome 
c in cytosolic fractions of Noxa-KO MEFs were largely unchanged upon 24-hour 
H202 exposure, indicating very little OMMP. However, the amounts of 
cytochrome c were notably higher in cytosolic fractions of wild-type cells after 14-
hour H202 treatment, consistent with previously reported role of NOXA in 
mediating H202-indcued apoptosis. As LMP was observed 30 minutes following 
H202 treatment in both wild-type and Noxa-KO MEF cells (Figure 4.1A), these 
results provide evidence that MOMP occurs following LMP during oxidative 
stress-induced apoptosis. 
As a direct result of increased OMMP, mitochondrial membrane potential 
decreases in cells undergoing apoptosis, which has been commonly used as an 
indicator of OMMP [155]. To determine the temporal relation between OMMP 
and LMP during H202-induced apoptosis, we measured mitochondrial membrane 
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potential at different time following an exposure to H202 using the mitochondrial 
potential-sensitive probe MitoTracker Red and the mitochondrial potential-
independent probe MitoTracker Green. An exposure to H20 2 led to a time-
dependent decrease in mitochondrial membrane potential in both wild-type and 
Noxa-KO MEFs, but mitochondrial membrane potential dissipated much faster in 
wild-type MEFs compared with Noxa-KO MEFs (Figure 4.28). 
In contrast to the occurrence of LMP 30 minutes following H202 treatment (Figure 
4.18), no changes in mitochondrial membrane potential were detected in either 
MEF cell line within one hour of H202 exposure. Even after 6 hours of H202 
exposure, mitochondrial membrane potential was reduced about 30% in wild-
type MEFs, whereas mitochondria in Noxa-KO MEFs were still intact. Twenty-
four hours of treatment with H202 almost completely disrupted mitochondrial 
membrane integrity in wild-type MEFs, but there was only about 25% reduction in 
mitochondrial membrane potential in Noxa-KO MEFs. Since Noxa-KO MEFs 
were more resistant to H202-induced OMMP, Noxa expression was important for 
OMMP induction, which is consistent with previous studies about the role of Noxa 
in H20 2-induced apoptosis [151]. Importantly, stabilizing lysosomal membranes 
by pre-incubation with DFO significantly inhibited H202-induced mitochondrial 
membrane potential reduction (Figure 4.2C). Thus, it is likely that mitochondrial 
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Figure 4.2. Mitochondria membrane permeabilization is dependent on Noxa 
expression. (A) Wild-type and Noxa-KO MEF cells were treated with 0.4 
mM H202. The amounts of cytochrome c in cytosolic fractions at the 
indicated time points were detected by western blot. (8) Following an 
exposure with 0.4 mM H202 for the indicated time, wild-type and Noxa-KO 
MEFs were incubated with 200 nM Mitotracker Red or 200 nM Mitotracker 
Green for 1 hour. Flow cytometer was used to measure red and green 
fluorescence intensity of MEFs. Mitochondrial membrane potential was 
calculated as the ratio of red to green fluorescence intensities and 
normalized. Experiments were performed in triplicates and mean ± 
standard deviation of three independent experiments is shown. (C) Wild-
type and Noxa-KO MEFs were pre-incubated with or without 1 mM DFO 
for two hours before a treatment with 0.4 mM H20 2 for 24 hours. Changes 
in red and green fluorescence intensities were determined and 
mitochondrial membrane potential was calculated as shown in (A). Data 
are presented as mean ± standard deviation of three independent 
experiments performed in triplicate. 
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4.3.3. LMP is essential for Noxa-mediated apoptosis in H202-treated cells. 
Since Noxa expression is critical for OMMP (Figure 4.2) but dispensable for LMP 
(Figure 4.1), we investigated the importance of LMP for Noxa-mediated 
apoptosis in H202-exposed cells. As expected, wild-type MEFs were more 
susceptible to H202 treatment compared with their Noxa-KO counterparts (Figure 
4.3A). Upon H202 exposure, Noxa-mediated apoptosis was abolished in cells 
pretreated with DFO, providing evidence that the impact of LMP on cellular 
responses to H202 depends on Noxa expression (Figure 4.3A). In addition, 
caspase 3/7 activity was measured following an exposure to H202. While there 
was more caspase 3/7 activity in wild-type MEFs than Noxa-KO MEFs, pre-
incubation with DFO significantly reduced caspase 3/7 activity in both cell lines 
(Figure 4.38). The correlation between caspase 3/7 activity and the level of cell 
death indicates that LMP exerts its influence on H202-induced apoptosis through 
endogenous Noxa. 
To further confirm the role of Noxa expression in H20 2-triggered LMP and 
subsequent apoptosis, Noxa expression in human colon cancer HCT116 cells 
was stably reduced by shRNA (Figure 4.3C). HCT116 cells with normal or 
reduced Noxa expression were exposed to H20 2 in the presence or absence of 
DFO pre-incubation. Consistent with the studies with MEFs (Figure 4.3A), the 
reduction of Noxa expression rendered HCT116 cells more resistant to H202 
treatment, validating the critical role of Noxa in H20 2-triggered apoptosis. 
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Furthermore, OFO pre-incubation abolished H202 cytotoxicity in HCT116 cells 
with normal Noxa expression (Figure 4.30), providing more evidence that the 
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Figure 4.3. Stabilizing lysosomal membrane by OFO inhibits Noxa-
dependent apoptosis induced by H202. (A) Wild-type and Noxa-KO 
MEFs were pre-incubated with or without 1 mM DFO for 2 hours. MEFs 
were then treated with 0.4 mM H202 for the indicated time, and cell 
viability was determined using a flow cytometry analysis. Data are 
presented as mean ± standard deviation of three different experiments 
that were carried out in triplicates. (8) Caspase 3/7 activity was measured 
after 2 hour-incubation with or without DFO followed by a treatment with 
0.4 mM H202 for 6 hours. Data shown are mean ± standard deviation of 
three independent experiments performed in triplicates. (C) Noxa 
expression of was reduced in HCT116 cells by a small hairpin RNA 
(shRNA). The expression levels of Noxa were determined by western blot. 
(0) The HCT116 cells with normal (shLuc) or reduced (shNoxa) Noxa 
expression were incubated with or without DFO for 2 hours before an 
exposure with 0.4 mM H20 2 for the indicated time, and cell viability was 
measured. Mean ± standard deviation of three independent experiments is 
presented. 
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4.3.4. LMP is not involved in the regulation of some apoptosis paradigms 
To examine whether the induction of LMP is also critical in other apoptosis 
paradigms, wild-type MEFs were treated with death stimuli that have diverse 
mechanisms of action, including the topoisomerase inhibitor etoposide, the DNA 
intercalating agent doxorubicin, the transcriptional inhibitor actinomycin 0, and 
the protein kinase inhibitor staurosporine. MEFs were pretreated with DFO for 2 
hours followed by a treatment with the respective death stimuli. Pre-incubation 
with DFO failed to prevent apoptosis induced by any of the four death stimuli 
examined (Figure 4.4A), indicating that LMP did not occur or was not involved in 
apoptosis signaling induced by any of these agents. These results demonstrate a 
specific role of LMP in regulating oxidative stress-induced apoptosis in MEFs. 
This was strengthened further by the observation that caspase 3/7 activity 
detected in MEFs treated with different death stimuli closely correlated with the 
cell viability measurements, and pre-incubation with DFO did not affect caspase 
3/7 activity (Figure 4.48). 
To determine further the relevance of LMP in apoptotic signaling pathways 
initiated by chemotherapeutic drugs, human HCT116 cells with different Noxa 
expression levels were treated with cisplatin or carboplatin, two anti-cancer 
agents whose cytotoxicity has also been shown to depend on Noxa expression. 
HCT116 cells expressing normal levels of Noxa were more sensitive to both 
agents compared with their Noxa knockdown counterparts (Figure 4.4C). 
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Importantly, DFO failed to antagonize the pro-apoptotic activity of both drugs, 
indicating that LMP is irrelevant in apoptotic signaling triggered by cisplatin or 
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Figure 4.4. DFO fails to prevent apoptosis induced by other apoptotic 
stimuli. (A) Wild-type MEFs were incubated with or without 1 mM DFO for 
2 hours, then treated with etoposide (5~M), doxorubicin (1 ~M), 
actinomycin D (0.2 ~g/ml), or staurosporine (5 nM) for the indicated time. 
Cell viability was determined using flow cytometry. Mean ± standard 
deviation of three independent experiments that were performed in 
triplicates is presented. (8) Caspase 3/7 activity was measured following 
12 hour-treatment with etoposide, doxorubicin, or staurosporine, or 9 hour-
treatment with actinomycin D using a fluorometric assay. Data are 
presented as mean ± standard deviation of three independent 
experiments performed in triplicate. (C) The human HCT116 cells (shLuc 
and shNoxa) were pre-incubated with or without 1 mM DFO for 2 hours 
before a treatment with cisplatin (50 IlM) or carboplatin (200 IlM). Cell 
viability was then measured using the PI exclusion method. Data are 
shown as mean ± standard deviation of three independent experiments 
carried out three times. 
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4.3.5. LMP is not involved in apoptosis induced by ectopic Noxa 
expression. 
As our studies have shown that stabilizing lysosomal membrane by DFO 
prevents Noxa-dependent apoptotic signaling triggered by H202 (Figure 4.3), it is 
possible that DFO directly antagonizes pro-apoptotic activities of Noxa. To 
explore this possibility, we examined whether DFO could affect the pro-apoptotic 
activities of ectopically expressed Noxa. As Noxa expression displays much 
higher killing activities in MEFs deficient in 8c1-XL expression (8c1-x-KO) 
compared with wild-type MEFs [151], both 8cl-x-KO and wild-type MEFs were 
pre-incubated with or without DFO before infection with retrovirus expressing 
Noxa. Unlike its activity on H202-induced apoptosis, DFO failed to prevent 
apoptosis induced by ectopic Noxa expression in both wild-type and 8c1-x-KO 
MEFs (Figure 4.5A). Caspase 3/7 activity measurments further validated the 
inability of DFO to antagonize pro-apoptotic activities of ectopic Noxa expression, 
indicating that DFO inhibits H202-induced apoptosis at a step upstream of Noxa 
expression (Figure 4.58) 
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Figure 4.5. DFO does not prevent apoptosis induced by ectopic Noxa 
expression. (A) Noxa was retrovirally expressed in wild-type and Bcl-x-
KO MEFs following a 2 hour-incubation with or without 1 mM DFO. Cell 
viability was measured at the indicated time using a flow cytometry 
analysis. Mean ± standard deviation of three independent experiments 
that were conducted in triplicate is shown. (8) Caspases 3/7 activity was 
determined in wild-type and BcI-x-KO MEFs using a fluorimetric assay 
upon pre-incubation with 1 mM DFO for 2 hours followed by retroviral 
infection for 14 hours. Mean ± standard deviation of three independent 
experiments is shown. 
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4.3.6. H202-induced increase in Noxa expression is mediated by LMP. 
As the induction of Noxa expression is critical for H202-induced apoptosis, we 
systematically examined the effect of LMP on the expression of pro-apoptotic 
BH3-only BcI-2 proteins in MEFs using microarray. While DFO itself did not 
significantly affect gene expression of BH3-only Bcl-2 proteins, stabilizing 
lysosomal membranes by DFO was able to abolish the effects of H202 on Noxa 
mRNA expression levels (Figure 4.6A). Quantitative real-time polymerase chain 
reaction (qPCR) experiments were also carried out to confirm that LMP mediates 
Noxa expression increase in oxidative stress-induced apoptosis (Figure 4.6B). 
Our studies have shown that Noxa expression mediates apoptosis-induced by 
H202 or cisplatin, but stabilizing lysosomal membrane by DFO was only able to 
prevent H202-induced but not cisplatin-triggered apoptosis (Figure 4.3). 
To explore the distinct roles of LMP in different Noxa-dependent apoptosis 
paradigms, we examined the effect of DFO on Noxa expression induced by H20 2 
and cisplatin respectively in HCT116 cells (Figure 4.6C). DFO abolished H20 2-
caused Noxa mRNA induction, but failed to prevent cisplatin-induced increase in 
Noxa mRNA expression, correlating with the inability of DFO to inhibit apoptosis 
induced by cisplatin. The results of these experiments further validate the unique 
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Figure 4.6. H202-induced increase in Noxa expression is specifically 
mediated by LMP. (A) Wild-type MEFs were pre-incubated with or 
without DFO for 2 hours, before treated with 0.4 mM H202 for 6 hours. 
Total RNA was extracted and microarray analysis was carried out to 
determine global changes in mRNA expression levels upon H202 
treatment. (8) A qPCR analysis was performed using the total RNA 
generated in (A) to validate the results generated by microarray analysis. 
Data are presented as mean ± standard deviation of three independent 
experiments performed in triplicates. (C) DFO prevented Noxa expression 
increase induced by H20 2 but not cisplatin. After pre-incubation with or 
without DFO for 2 hours, HCT116 cells (shLuc) were treated with either 
0.4 mM H202 for 6 hours or 50 IlM cisplatin for 14 hours. Total RNA was 
collected and a qPCR analysis was performed to determine Noxa mRNA 
levels. Mean ± standard deviation of three independent experiments is 
presented. **P<0.01; ***P<0.001; Student's unpaired t test. ns, no 
significance. 
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4.3.7. Iron overload specifically enhances Noxa expression 
Lysosomal labile iron has been shown to translocate to the nucleus and cause 
oxidative damage to DNA during oxidative stress-induced apoptosis [134-136]. 
Therefore, it is possible that redox active iron released into the cytosol might be 
responsible for LMP-induced Noxa expression. To examine this possibility, the 
effects of exogenous iron on changes in global mRNA expression were 
determined by microarray experiments performed in wild-type MEFs treated with 
ferric ammonium citrate. Upon iron exposure, the most prominent increase in 
gene expression in the BH3-only BcI-2 protein family was Noxa, which was 
similar to the expression profile of H202 exposure (Figure 4.7 A). The degree of 
Noxa induction in iron-loaded cells was modest compared with that observed in 
cells exposed to H202 (Figure 4.6A), which could be attributed to the different 
array types used in these experiments. DFO was able to prevent iron-induced 
increase in Noxa expression but had little effect on the mRNA expression levels 
of other BH3-only Bcl-2 proteins. The qPCR analyses further confirmed that 
exogenous iron specifically induced Noxa mRNA expression level (Figure 4.7B). 
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Figure 4.7. Exogenous iron specifically increases Noxa expression. (A) 
Wild-type MEFs were pre-incubated with DFO before treatment with 0.3 
mM iron ammonium citrate for 24 hours. Total RNA was extracted and 
used for microarray experiments to determine changes in mRNA 
expression levels. (8) Total RNA described in (A) was used for a qPCR 
analysis to determine Noxa mRNA expression levels. Mean ± standard 
deviation of three independent triplicate experiments is presented. 
*P<0 .05 ; Student's unpaired t test. 
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4.4. Discussion 
Oxidative stress-triggered LMP is well documented, but the detailed mechanisms 
through which LMP is coupled with OMMP and eventual apoptosis are still 
unclear. Here we investigated the role of lysosomal membrane rupture in 
regulating apoptosis caused by the oxidative stress inducer H202. Upon H202 
exposure, the integrity of lysosomal membranes was disrupted independent of 
endogenous Noxa, despite its essential role in apoptosis signaling. Noxa-
dependent OMMP appeared to occur downstream of LMP. Stabilizing lysosomal 
membranes specifically inhibited Noxa expression increase and Noxa-mediated 
apoptosis in H202-treated cells. Overall, our studies provide molecular evidence 
that LMP modulates cellular responses to oxidative stress by regulating Noxa 
expression. 
The mechanisms of apoptosis signaling induced by LMP have been under 
intensive study. It is generally believed that the rupture of lysosome membranes 
releases hydrolytic enzymes normally resided inside Iysosomes into the cytosol, 
which may in turn trigger apoptotic signaling by hydrolyzing their substrates 
[149]. However, severe lysosomal membrane damage leads to a massive exodus 
of lysosomal enzymes into the cytosol, indiscriminately digesting cellular 
components, causing deleterious cytoplasmic acidification, and inducing necrosis 
instead of apoptosis. The concentration of H202 examined in our studies induced 
maximal apoptotic cell death but minimal necrosis in MEFs [151]. In this oxidative 
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stress paradigm, the induction of OMMP and subsequent apoptosis depended on 
Noxa expression (Figures 4.2 and 4.3). On the contrary, both early and late 
lysosomal membrane rupture occurred at same rates in wild-type and Noxa-KO 
MEFs (Figure 4.1), suggesting that hydrolytic activities of discharged lysosomal 
enzymes are unlikely to be responsible for initiating more prominent apoptotic 
cascades in Noxa-expressing cells. It is conceivable that partial lysosomal 
damage under the conditions in our studies only promotes limited release of 
lysosomal enzymes whose concentrations in the cytosol are not high enough to 
trigger apoptosis by themselves. Instead, the induction of Noxa expression by 
LMP is responsible for oxidative stress-induced apoptosis in MEFs. Thus, the 
strength of oxidative insults and the cell type could determine how apoptotic 
signaling is activated in response to oxidative insults. 
Recent studies have demonstrated that both anti- and pro-apoptotic BcI-2 
proteins are involved in apoptotic signaling initiated by LMP. Overexpressing 
anti-apoptotic BcI-2 in murine histiocytic lymphoma cells suppresses oxidant-
induced apoptosis by stabilizing lysosomal membranes and the phosphorylation 
of BcI-2 is required for this activity [124, 125]. In multiple apoptosis paradigms, 
Bax has been shown to translocate to Iysosomes to mediate LMP, probably by 
oligomerizing and forming permeation channels on lysosomal membranes [156, 
157]. Upon TNFa treatment, tBid is generated by caspase 8 and induces Bid-
dependent lysosomal membrane rupture, leading to discharge of the lysosomal 
protease cathepsin B into the cytosol and eventual apoptosis [158, 159]. Given 
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that Noxa expression is dispensable for LMP induction in response to oxidative 
stress, Noxa likely functions at the mitochondrial level to mediate apoptosis, 
which is supported by our evidence about temporal relation of OMMP and LMP in 
H202-treated cells (Figures 4.1 and 4.2). 
Although originally identified as a primary p53-response protein, Noxa expression 
increases in response to diverse apoptotic stimuli, including some 
chemotherapeutic agents [160]. Our studies indicate that during H202-induced 
apoptosis LMP induced Noxa expression increases in both MEFs and HCT116 
cells (Figure 4.6). This induction of Noxa is unlikely caused by p53 activation, 
since MEFs examined in our studies have been immortalized by SV40 T antigen, 
a known p53 deactivator [151]. In contrast, the increase in Noxa expression in 
cells exposed to cisplatin or cisplatin-related compounds could depend on p53 
[158, 161]. Thus, the different effects of stabilizing lysosomal membranes by 
DFO on cisplatin- or H202-induced apoptosis could be attributed to the underlying 
mechanisms of Noxa induction in these two apoptosis paradigms. 
Lysosomes contain abundant labile iron, and the rupture of lysosomal membrane 
leads to redox-active iron translocation to the nucleus during oxidative stress 
[134, 135]. I reasoned that lysosomal redox-active iron might be responsible for 
subsequent transcriptional responses to oxidative responses, particularly pro-
apoptotic BcI-2 proteins. Indeed, the transcription profile of BH3-only Bcl-2 
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proteins in cells loaded with exogenous iron recapitulated that of cells undergoing 
oxidative stress (Figure 4.7), suggesting that LMP-triggered apoptosis signaling 
is transduced into the nucleus to induce Noxa transcription via released 
lysosomal redox-active iron. In support of this model, lysosomal redox-active iron 
has been reported to generate oxidative damage to DNA [136] and Noxa is 
known to be a DNA damage-responsive protein [160]. In summary, our studies 
reveal a novel mechanism by which lysosomal membrane stability regulates 
H20 2-induced apoptosis. Future research will focus on investigating the signaling 
pathway, particularly the involvement of redox-active iron, in the induction of 
Noxa expression. 
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Figure 4.8. Oxidative stress-induced LMP promotes Noxa-dependent 
apoptosis. In Iysosomes, the oxidative stress inducer H202 interacts with 
intralysosomal iron to generate highly reactive hydroxyl radicals and 
induce subsequent LMP, which can be inhibited by the iron chelating 
agent DFO. LMP leads to an increase in Noxa expression, which in turn 




5.1. Summary and conclusions 
Previous studies have shown that overexpression of the anti-apoptotic Bcl-2 
protein BcI-XL prevents apoptosis initiated by diverse apoptotic stimuli. The exact 
mechanism of how BcI-XL prevents apoptosis is still unclear and controversial. As 
BcI-XL likely functions to modulate OMM integrity, overexpression of Bcl-XL could 
relocate BcI-XL to non-physiological locations inside cells, leading to unexpected 
biological consequences. Therefore, studying the activities of Bcl-XL at 
endogenous levels will fill critical gaps in our understanding of the molecular and 
biochemical mechanisms by which Bcl-XL regulates apoptosis. 
Endogenous Bcl-XL has been demonstrated to localize in the mitochondria, the 
ER, and the cytosol. I investigated the molecular functions of Bcl-XL exclusively 
localized in a particular subcellular compartment on regulation of apoptosis and 
Ca2+ homeostasis using MEFs. The carboxyl-terminal transmembrane domain of 
BcI-XL was deleted to confine Bcl-XL specifically to the cytosol. The carboxyl-
terminus of BcI-XL was replaced with either the mitochondria targeting sequence 
of the Listeria protein ActA or the ER targeting sequence of cytochrome bS (cbS), 
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which targets Bcl-XL to the mitochondria or the ER respectively. Targeting BcI-XL 
at the mitochondria but not at the ER prevented apoptosis induced by diverse 
death stimuli to the degree observed in wild-type MEFs. However, expression of 
ER-targeted Bcl-XL but not mitochondrially targeted BcI-xL was required to 
modulate Ca2+ homeostasis. Of importance, ER-targeted BcI-xL was able to 
prptect cells against death stimuli in the presence of endogenous Bcl-XL. These 
data indicate that mitochondrial BcI-xL can regulate apoptosis independently of 
ER Bcl-XL and that when localized exclusively at the ER, BcI-XL impinges on Ca2+ 
homeostasis but does not affect apoptosis unless Bcl-XL is present in additional 
cellular compartments. 
Next I investigated how endogenous BcI-xL regulates oxidative stress-induced 
apoptosis. Oxidative stress has been known to induce both necrosis and 
apoptosis dependent on the severity of the oxidative stress to cells. Mild to 
moderate oxidative stress causes apoptosis whereas severe oxidative stress 
triggers necrosis [93, 151]. The exact mechanism through which oxidative stress 
inducers, including H20 2, promote apoptosis is unclear but recent evidence 
suggests the involvement of the Bcl-2 proteins. Thus, I investigated how the 
complex Bcl-2 protein network might regulate oxidative stress-induced apoptosis. 
Using MEFs, I found out that endogenous BcI-XL prevented apoptosis initiated by 
H202. Furthermore, the pro-apoptotic BH3-only Bcl-2 protein Noxa was required 
for H202-induced apoptosis and was the only BH3-only BcI-2 protein whose pro-
apoptotic activity was completely antagonized by endogenous BcI-XL. Upon H202 
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treatment, Noxa mRNA displayed the greatest increase among BH3-only Bcl-2 
proteins. Also, expression levels of the anti-apoptotic BcI-2 protein McI-1, the 
primary binding target of Noxa, were greatly reduced in cells treated with H202 in 
a Noxa-dependent fashion, and McI-1 overexpression prevent H20 2-induced 
apoptosis. Overall, these studies reveal a signaling pathway in which H20 2 
activates Noxa, leading to a decrease in McI-1 expression and subsequent cell 
death in the absence of BcI-XL expression. Therefore, both anti-apoptotic and 
pro-apoptotic BcI-2 proteins cooperate to regulate oxidative stress-induced 
apoptosis. 
Finally, I investigated the important role of lysosomal membrane permeabilization 
(LMP) during oxidative stress-induced apoptosis. Previous studies have 
implicated LMP in oxidative stress-induced apoptosis, but the exact role of LMP 
in oxidative stress-triggered apoptotic cascade or how it is regulated by the BcI-2 
protein network is not completely understood. Here, I determined the temporal 
relation between LMP and OMMP using MEFs deficient in Noxa and their wild-
type counterparts. Although Noxa expression was important for H202-triggered 
OMMP and subsequent apoptosis, H202-induced LMP was independent of Noxa 
expression. However, Noxa-dependent OMMP induction occurred downstream of 
LMP. When the lysosomal membranes were stabilized by the iron chelating 
agent DFO, H202-induced increase in Noxa expression and subsequent 
apoptosis was prevented probably by inhibition of LMP. DFO prevented H202-
induced increase in Noxa expression but failed to prevent cisplatin-caused Noxa 
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expression induction, indicating that LMP is unique for oxidative stress-triggered 
apoptosis. Thus these studies reveal a novel signaling pathway for H20 2-induced 
apoptosis, in which an increase in Noxa expression couples LMP with OMMP 
and ultimate apoptosis. 
5.2. Future perspectives 
Further research will focus on investigating the signaling pathway, particularly 
lysosomal redox-active iron, involved in the regulation of Noxa expression. 
Because DNA damage causes increase in p53 proteins which in turn activates 
Noxa expression, I will further explore the involvement of H202 in DNA damage, 
activation of p53 proteins, increase in Noxa expression and subsequent 
apoptosis. I will also further elucidate the involvement of the crosstalk between 
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